CHEBI ONTOLOGY - ANNOTATIONS |
|
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
|
Term: | defoliant |
|
Accession: | CHEBI:23582
|
browse the term
|
Definition: | A herbicide which when sprayed or dusted on plants causes its leaves to fall off. |
Synonyms: | related_synonym: | Defoliationsmittel; Entlaubungsmittel; defoliants |
|
|
|
G |
Abca7 |
ATP binding cassette subfamily A member 7 |
increases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in increased expression of ABCA7 mRNA |
CTD |
PMID:18579281 |
|
NCBI chr 7:9,691,452...9,711,466
Ensembl chr 7:9,691,449...9,711,425
|
|
G |
Abcb4 |
ATP binding cassette subfamily B member 4 |
increases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in increased expression of ABCB4 mRNA |
CTD |
PMID:9210621 |
|
NCBI chr 4:25,150,998...25,209,489
Ensembl chr 4:25,151,953...25,209,202
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
increases expression multiple interactions |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in increased expression of ABCC2 mRNA; 2,4,5-Trichlorophenoxyacetic Acid results in increased expression of ABCC2 protein Alpha-Amanitin inhibits the reaction [2,4,5-Trichlorophenoxyacetic Acid results in increased expression of ABCC2 mRNA] |
CTD |
PMID:10377250 PMID:16426233 |
|
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
|
|
G |
Acap3 |
ArfGAP with coiled-coil, ankyrin repeat and PH domains 3 |
decreases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in decreased expression of ACAP3 mRNA |
CTD |
PMID:18579281 |
|
NCBI chr 5:166,501,150...166,515,477
Ensembl chr 5:166,500,781...166,515,481
|
|
G |
Acer2 |
alkaline ceramidase 2 |
decreases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in decreased expression of ACER2 mRNA |
CTD |
PMID:18579281 |
|
NCBI chr 5:101,391,830...101,442,615
Ensembl chr 5:101,391,885...101,442,614
|
|
G |
Adgrb2 |
adhesion G protein-coupled receptor B2 |
increases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in increased expression of ADGRB2 mRNA |
CTD |
PMID:18579281 |
|
NCBI chr 5:142,299,190...142,362,540
Ensembl chr 5:142,331,329...142,362,540
|
|
G |
Adh4 |
alcohol dehydrogenase 4 (class II), pi polypeptide |
increases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in increased expression of ADH4 mRNA |
CTD |
PMID:18579281 |
|
NCBI chr 2:226,948,717...226,966,747
Ensembl chr 2:226,947,466...226,987,591
|
|
G |
Alpi |
alkaline phosphatase, intestinal |
decreases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in decreased expression of ALPI mRNA |
CTD |
PMID:18579281 |
|
NCBI chr 9:87,773,411...87,776,877
Ensembl chr 9:87,773,411...87,776,877
|
|
G |
Ar |
androgen receptor |
affects binding |
EXP |
2,4,5-Trichlorophenoxyacetic Acid binds to AR protein |
CTD |
PMID:14565775 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Arhgap32 |
Rho GTPase activating protein 32 |
increases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in increased expression of ARHGAP32 mRNA |
CTD |
PMID:18579281 |
|
NCBI chr 8:30,421,269...30,681,653
Ensembl chr 8:30,421,515...30,678,454
|
|
G |
Arsg |
arylsulfatase G |
increases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in increased expression of ARSG mRNA |
CTD |
PMID:18579281 |
|
NCBI chr10:94,412,261...94,551,224
Ensembl chr10:94,447,399...94,542,941
|
|
G |
Basp1 |
brain abundant, membrane attached signal protein 1 |
increases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in increased expression of BASP1 mRNA |
CTD |
PMID:18579281 |
|
NCBI chr 2:75,816,130...75,863,801
Ensembl chr 2:75,816,122...75,864,043
|
|
G |
C1qtnf4 |
C1q and TNF related 4 |
increases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in increased expression of C1QTNF4 mRNA |
CTD |
PMID:18579281 |
|
NCBI chr 3:76,854,368...76,872,991
Ensembl chr 3:76,857,735...76,874,139
|
|
G |
Cacnb3 |
calcium voltage-gated channel auxiliary subunit beta 3 |
increases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in increased expression of CACNB3 mRNA |
CTD |
PMID:18579281 |
|
NCBI chr 7:129,784,799...129,797,074
Ensembl chr 7:129,783,674...129,797,074
|
|
G |
Camk1d |
calcium/calmodulin-dependent protein kinase ID |
increases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in increased expression of CAMK1D mRNA |
CTD |
PMID:18579281 |
|
NCBI chr17:72,581,899...72,982,704
Ensembl chr17:72,581,979...72,980,556
|
|
G |
Capn6 |
calpain 6 |
decreases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in decreased expression of CAPN6 mRNA |
CTD |
PMID:18579281 |
|
NCBI chr X:107,380,774...107,405,489
Ensembl chr X:107,380,774...107,405,489
|
|
G |
Cdh1 |
cadherin 1 |
increases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in increased expression of CDH1 mRNA |
CTD |
PMID:18579281 |
|
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
|
|
G |
Cirbp |
cold inducible RNA binding protein |
increases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in increased expression of CIRBP mRNA |
CTD |
PMID:18579281 |
|
NCBI chr 7:9,533,857...9,538,899
Ensembl chr 7:9,424,178...9,538,818
|
|
G |
Ckm |
creatine kinase, M-type |
increases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in increased expression of CKM mRNA |
CTD |
PMID:18579281 |
|
NCBI chr 1:79,061,390...79,071,721
Ensembl chr 1:79,061,456...79,071,720
|
|
G |
Clca4 |
chloride channel accessory 4 |
decreases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in decreased expression of CLCA4A mRNA |
CTD |
PMID:18579281 |
|
NCBI chr 2:233,883,625...233,904,993
Ensembl chr 2:233,883,851...233,903,089
|
|
G |
Col15a1 |
collagen type XV alpha 1 chain |
increases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in increased expression of COL15A1 mRNA |
CTD |
PMID:18579281 |
|
NCBI chr 5:61,501,963...61,607,591
Ensembl chr 5:61,501,963...61,607,591
|
|
G |
Cyp7b1 |
cytochrome P450 family 7 subfamily B member 1 |
increases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in increased expression of CYP7B1 mRNA |
CTD |
PMID:18579281 |
|
NCBI chr 2:100,502,791...100,669,713
Ensembl chr 2:100,502,791...100,669,698
|
|
G |
Ddc |
dopa decarboxylase |
increases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in increased expression of DDC mRNA |
CTD |
PMID:18579281 |
|
NCBI chr14:86,378,685...86,469,189
Ensembl chr14:86,378,685...86,469,208
|
|
G |
Eepd1 |
endonuclease/exonuclease/phosphatase family domain containing 1 |
increases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in increased expression of EEPD1 mRNA |
CTD |
PMID:18579281 |
|
NCBI chr 8:23,957,258...24,064,343
Ensembl chr 8:23,957,255...24,064,340
|
|
G |
Ephx1 |
epoxide hydrolase 1 |
increases activity |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in increased activity of EPHX1 protein |
CTD |
PMID:3032197 |
|
NCBI chr13:92,714,315...92,744,105
Ensembl chr13:92,714,315...92,790,235
|
|
G |
Ephx2 |
epoxide hydrolase 2 |
multiple interactions |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in increased expression of and results in increased activity of EPHX2 protein |
CTD |
PMID:3032197 |
|
NCBI chr15:40,289,901...40,327,632
Ensembl chr15:40,289,902...40,327,615
|
|
G |
Esr1 |
estrogen receptor 1 |
multiple interactions |
ISO |
2,4,5-Trichlorophenoxyacetic Acid binds to and results in decreased activity of ESR1 protein |
CTD |
PMID:16626760 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Far1 |
fatty acyl CoA reductase 1 |
decreases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in decreased expression of FAR1 mRNA |
CTD |
PMID:18579281 |
|
NCBI chr 1:167,644,622...167,705,868
Ensembl chr 1:167,644,677...167,705,730
|
|
G |
Fkbp5 |
FKBP prolyl isomerase 5 |
decreases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in decreased expression of FKBP5 mRNA |
CTD |
PMID:18579281 |
|
NCBI chr20:6,457,207...6,575,404
Ensembl chr20:6,457,216...6,541,674
|
|
G |
Fmo2 |
flavin containing dimethylaniline monoxygenase 2 |
decreases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in decreased expression of FMO2 mRNA |
CTD |
PMID:18579281 |
|
NCBI chr13:75,221,149...75,244,377
Ensembl chr13:75,224,402...75,244,308
|
|
G |
G0s2 |
G0/G1switch 2 |
decreases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in decreased expression of G0S2 mRNA |
CTD |
PMID:18579281 |
|
NCBI chr13:104,806,351...104,807,263
Ensembl chr13:104,806,156...104,807,451
|
|
G |
Gbf1 |
golgi brefeldin A resistant guanine nucleotide exchange factor 1 |
increases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in increased expression of GBF1 mRNA |
CTD |
PMID:18579281 |
|
NCBI chr 1:245,018,535...245,147,052
Ensembl chr 1:245,018,568...245,147,042
|
|
G |
Gbp6 |
guanylate binding protein family member 6 |
increases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in increased expression of GBP9 mRNA |
CTD |
PMID:18579281 |
|
NCBI chr14:4,730,286...4,756,508
Ensembl chr14:4,730,453...4,839,062 Ensembl chr14:4,730,453...4,839,062
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
increases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in increased expression of GCLC mRNA 2,4,5-Trichlorophenoxyacetic Acid results in increased expression of GCLC; 2,4,5-Trichlorophenoxyacetic Acid results in increased expression of GCLC mRNA |
CTD |
PMID:10377250 PMID:16426233 |
|
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
|
|
G |
Gde1 |
glycerophosphodiester phosphodiesterase 1 |
decreases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in decreased expression of GDE1 mRNA |
CTD |
PMID:18579281 |
|
NCBI chr 1:173,016,984...173,032,396
Ensembl chr 1:172,954,394...173,032,429
|
|
G |
Gfra1 |
GDNF family receptor alpha 1 |
decreases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in decreased expression of GFRA1 mRNA |
CTD |
PMID:18579281 |
|
NCBI chr 1:257,315,682...257,552,004
Ensembl chr 1:257,321,742...257,551,473
|
|
G |
Git2 |
GIT ArfGAP 2 |
decreases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in decreased expression of GIT2 mRNA |
CTD |
PMID:18579281 |
|
NCBI chr12:41,829,717...41,872,621
Ensembl chr12:41,829,730...41,871,097
|
|
G |
Gmppb |
GDP-mannose pyrophosphorylase B |
increases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in increased expression of GMPPB mRNA |
CTD |
PMID:18579281 |
|
NCBI chr 8:108,737,429...108,740,437
Ensembl chr 8:108,693,060...108,767,286
|
|
G |
Got1 |
glutamic-oxaloacetic transaminase 1 |
decreases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in decreased expression of GOT1 mRNA |
CTD |
PMID:18579281 |
|
NCBI chr 1:242,357,293...242,381,535
Ensembl chr 1:242,357,306...242,380,633
|
|
G |
Gpm6a |
glycoprotein m6a |
decreases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in decreased expression of GPM6A mRNA |
CTD |
PMID:18579281 |
|
NCBI chr16:36,641,282...36,973,377
Ensembl chr16:36,641,284...36,973,475
|
|
G |
Gpr12 |
G protein-coupled receptor 12 |
increases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in increased expression of GPR12 mRNA |
CTD |
PMID:18579281 |
|
NCBI chr12:8,522,709...8,525,875
Ensembl chr12:8,522,953...8,527,973
|
|
G |
Gpr85 |
G protein-coupled receptor 85 |
decreases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in decreased expression of GPR85 mRNA |
CTD |
PMID:18579281 |
|
NCBI chr 4:42,100,138...42,109,584
Ensembl chr 4:42,102,941...42,109,566
|
|
G |
Hapln1 |
hyaluronan and proteoglycan link protein 1 |
decreases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in decreased expression of HAPLN1 mRNA |
CTD |
PMID:18579281 |
|
NCBI chr 2:20,631,640...20,696,388
Ensembl chr 2:20,631,640...20,693,777
|
|
G |
Hmox1 |
heme oxygenase 1 |
decreases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in decreased expression of HMOX1 mRNA |
CTD |
PMID:18579281 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hspa8 |
heat shock protein family A (Hsp70) member 8 |
decreases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in decreased expression of HSPA8 mRNA |
CTD |
PMID:18579281 |
|
NCBI chr 8:41,183,397...41,187,260
Ensembl chr 8:41,183,264...41,187,259
|
|
G |
Hspb1 |
heat shock protein family B (small) member 1 |
decreases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in decreased expression of HSPB1 mRNA |
CTD |
PMID:18579281 |
|
NCBI chr12:20,794,014...20,795,675
Ensembl chr12:20,794,028...20,795,743
|
|
G |
Hsph1 |
heat shock protein family H (Hsp110) member 1 |
decreases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in decreased expression of HSPH1 mRNA |
CTD |
PMID:18579281 |
|
NCBI chr12:5,390,916...5,410,224
Ensembl chr12:5,390,922...5,410,224
|
|
G |
Ido2 |
indoleamine 2,3-dioxygenase 2 |
increases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in increased expression of IDO2 mRNA |
CTD |
PMID:18579281 |
|
NCBI chr16:67,459,158...67,498,052
Ensembl chr16:67,459,190...67,496,324
|
|
G |
Ihh |
Indian hedgehog signaling molecule |
increases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in increased expression of IHH mRNA |
CTD |
PMID:18579281 |
|
NCBI chr 9:76,504,315...76,510,532
Ensembl chr 9:76,504,315...76,510,532
|
|
G |
Ikbke |
inhibitor of nuclear factor kappa B kinase subunit epsilon |
increases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in increased expression of IKBKE mRNA |
CTD |
PMID:18579281 |
|
NCBI chr13:42,712,154...42,738,470
Ensembl chr13:42,712,159...42,737,143
|
|
G |
Il1r1 |
interleukin 1 receptor type 1 |
decreases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in decreased expression of IL1R1 mRNA |
CTD |
PMID:18579281 |
|
NCBI chr 9:42,504,917...42,580,958
Ensembl chr 9:42,504,735...42,579,937
|
|
G |
Insc |
INSC, spindle orientation adaptor protein |
increases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in increased expression of INSC mRNA |
CTD |
PMID:18579281 |
|
NCBI chr 1:168,993,032...169,100,438
Ensembl chr 1:168,993,032...169,100,433
|
|
G |
Klf5 |
KLF transcription factor 5 |
increases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in increased expression of KLF5 mRNA |
CTD |
PMID:18579281 |
|
NCBI chr15:76,060,320...76,079,445
Ensembl chr15:76,064,258...76,079,445
|
|
G |
Limch1 |
LIM and calponin homology domains 1 |
decreases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in decreased expression of LIMCH1 mRNA |
CTD |
PMID:18579281 |
|
NCBI chr14:41,112,579...41,425,001
Ensembl chr14:41,114,803...41,425,191
|
|
G |
Lmcd1 |
LIM and cysteine-rich domains 1 |
increases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in increased expression of LMCD1 mRNA |
CTD |
PMID:18579281 |
|
NCBI chr 4:145,393,153...145,452,049
Ensembl chr 4:145,393,145...145,452,046
|
|
G |
Lpar4 |
lysophosphatidic acid receptor 4 |
decreases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in decreased expression of LPAR4 mRNA |
CTD |
PMID:18579281 |
|
NCBI chr X:72,033,486...72,046,978
Ensembl chr X:72,033,486...72,046,977
|
|
G |
Lpin1 |
lipin 1 |
decreases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in decreased expression of LPIN1 mRNA |
CTD |
PMID:18579281 |
|
NCBI chr 6:39,309,198...39,417,034
Ensembl chr 6:39,312,748...39,417,097
|
|
G |
Lrtm1 |
leucine-rich repeats and transmembrane domains 1 |
increases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in increased expression of LRTM1 mRNA |
CTD |
PMID:18579281 |
|
NCBI chr16:4,210,343...4,217,843
|
|
G |
Matk |
megakaryocyte-associated tyrosine kinase |
increases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in increased expression of MATK mRNA |
CTD |
PMID:18579281 |
|
NCBI chr 7:8,456,990...8,465,947
Ensembl chr 7:8,456,998...8,462,022
|
|
G |
Mpdz |
multiple PDZ domain crumbs cell polarity complex component |
increases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in increased expression of MPDZ mRNA |
CTD |
PMID:18579281 |
|
NCBI chr 5:95,766,112...95,920,531
Ensembl chr 5:95,766,118...95,920,499
|
|
G |
Mt1 |
metallothionein 1 |
decreases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in decreased expression of MT1 mRNA |
CTD |
PMID:18579281 |
|
NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049 Ensembl chr17:10,826,032...10,827,049
|
|
G |
Mt4 |
metallothionein 4 |
decreases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in decreased expression of MT4 mRNA |
CTD |
PMID:18579281 |
|
NCBI chr19:10,863,813...10,865,909
Ensembl chr19:10,863,813...10,865,909
|
|
G |
Mvd |
mevalonate diphosphate decarboxylase |
increases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in increased expression of MVD mRNA |
CTD |
PMID:18579281 |
|
NCBI chr19:50,496,366...50,506,429
Ensembl chr19:50,496,367...50,507,971
|
|
G |
Mybph |
myosin binding protein H |
increases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in increased expression of MYBPH mRNA |
CTD |
PMID:18579281 |
|
NCBI chr13:45,653,156...45,660,893
Ensembl chr13:45,653,234...45,660,893
|
|
G |
Ndrg4 |
NDRG family member 4 |
decreases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in decreased expression of NDRG4 mRNA |
CTD |
PMID:18579281 |
|
NCBI chr19:9,351,408...9,387,398
Ensembl chr19:9,351,404...9,386,914
|
|
G |
Nherf4 |
NHERF family PDZ scaffold protein 4 |
decreases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in decreased expression of NHERF4 mRNA |
CTD |
PMID:18579281 |
|
NCBI chr 8:44,584,390...44,588,838
Ensembl chr 8:44,584,390...44,588,860
|
|
G |
Nip7 |
nucleolar pre-rRNA processing protein NIP7 |
decreases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in decreased expression of NIP7 mRNA |
CTD |
PMID:18579281 |
|
NCBI chr19:34,962,557...34,964,700
Ensembl chr19:34,962,557...34,964,711
|
|
G |
Nrg4 |
neuregulin 4 |
decreases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in decreased expression of NRG4 mRNA |
CTD |
PMID:18579281 |
|
NCBI chr 8:55,586,253...55,677,829
Ensembl chr 8:55,592,893...55,677,483
|
|
G |
Ogn |
osteoglycin |
decreases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in decreased expression of OGN mRNA |
CTD |
PMID:18579281 |
|
NCBI chr17:15,032,069...15,052,626
Ensembl chr17:15,032,069...15,052,739
|
|
G |
Or5b99 |
olfactory receptor family 5 subfamily B member 99 |
increases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in increased expression of OR5B99 mRNA |
CTD |
PMID:18579281 |
|
NCBI chr 1:210,136,841...210,137,767
Ensembl chr 1:210,132,946...210,138,365
|
|
G |
Pfkp |
phosphofructokinase, platelet |
decreases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in decreased expression of PFKP mRNA |
CTD |
PMID:18579281 |
|
NCBI chr17:63,729,743...63,794,026
Ensembl chr17:63,729,780...63,794,018
|
|
G |
Plin4 |
perilipin 4 |
decreases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in decreased expression of PLIN4 mRNA |
CTD |
PMID:18579281 |
|
NCBI chr 9:929,168...938,062
Ensembl chr 9:929,176...938,056
|
|
G |
Por |
cytochrome p450 oxidoreductase |
decreases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in decreased expression of POR mRNA |
CTD |
PMID:18579281 |
|
NCBI chr12:20,951,058...20,999,198
Ensembl chr12:20,951,058...20,999,245
|
|
G |
Ppfibp1 |
PPFIA binding protein 1 |
decreases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in decreased expression of PPFIBP1 mRNA |
CTD |
PMID:18579281 |
|
NCBI chr 4:179,807,579...179,951,428
Ensembl chr 4:179,808,794...179,951,428
|
|
G |
Ppp1r3a |
protein phosphatase 1, regulatory subunit 3A |
decreases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in decreased expression of PPP1R3A mRNA |
CTD |
PMID:18579281 |
|
NCBI chr 4:42,937,353...42,980,195
Ensembl chr 4:42,939,599...42,980,638
|
|
G |
Ppp1r3g |
protein phosphatase 1, regulatory subunit 3G |
decreases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in decreased expression of PPP1R3G mRNA |
CTD |
PMID:18579281 |
|
NCBI chr17:28,874,956...28,878,288
Ensembl chr17:28,876,482...28,877,525
|
|
G |
Prok1 |
prokineticin 1 |
increases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in increased expression of PROK1 mRNA |
CTD |
PMID:18579281 |
|
NCBI chr 2:194,850,539...194,859,343
Ensembl chr 2:194,853,991...194,859,250
|
|
G |
Prr9 |
proline rich 9 |
decreases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in decreased expression of PRR9 mRNA |
CTD |
PMID:18579281 |
|
NCBI chr 2:177,599,483...177,600,849
Ensembl chr 2:177,599,483...177,600,849
|
|
G |
Ptp4a1 |
protein tyrosine phosphatase 4A1 |
decreases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in decreased expression of PTP4A1 mRNA |
CTD |
PMID:18579281 |
|
NCBI chr 9:33,214,201...33,245,046
Ensembl chr 9:33,214,208...33,221,964
|
|
G |
Retreg1 |
reticulophagy regulator 1 |
decreases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in decreased expression of RETREG1 mRNA |
CTD |
PMID:18579281 |
|
NCBI chr 2:76,335,609...76,474,817
Ensembl chr 2:76,335,609...76,493,898
|
|
G |
Rprd1a |
regulation of nuclear pre-mRNA domain containing 1A |
decreases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in decreased expression of RPRD1A mRNA |
CTD |
PMID:18579281 |
|
NCBI chr18:15,791,418...15,839,338
Ensembl chr18:15,791,418...15,839,338
|
|
G |
Selenop |
selenoprotein P |
decreases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in decreased expression of SELENOP mRNA |
CTD |
PMID:18579281 |
|
NCBI chr 2:52,498,123...52,508,409
Ensembl chr 2:52,498,339...52,508,852
|
|
G |
Sema3c |
semaphorin 3C |
decreases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in decreased expression of SEMA3C mRNA |
CTD |
PMID:18579281 |
|
NCBI chr 4:17,583,212...17,747,234
Ensembl chr 4:17,583,212...17,746,534
|
|
G |
Sgk2 |
serum/glucocorticoid regulated kinase 2 |
increases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in increased expression of SGK2 mRNA |
CTD |
PMID:18579281 |
|
NCBI chr 3:151,644,102...151,669,480
Ensembl chr 3:151,644,102...151,669,480
|
|
G |
Slc24a2 |
solute carrier family 24 member 2 |
increases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in increased expression of SLC24A2 mRNA |
CTD |
PMID:18579281 |
|
NCBI chr 5:101,497,916...101,741,840
Ensembl chr 5:101,502,278...101,739,337
|
|
G |
Slc25a32 |
solute carrier family 25 member 32 |
decreases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in decreased expression of SLC25A32 mRNA |
CTD |
PMID:18579281 |
|
NCBI chr 7:70,142,958...70,160,726
Ensembl chr 7:70,142,964...70,160,770
|
|
G |
Slc66a1 |
solute carrier family 66 member 1 |
increases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in increased expression of SLC66A1 mRNA |
CTD |
PMID:18579281 |
|
NCBI chr 5:151,537,870...151,552,259
Ensembl chr 5:151,542,376...151,552,259
|
|
G |
Slc6a15 |
solute carrier family 6 member 15 |
decreases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in decreased expression of SLC6A15 mRNA |
CTD |
PMID:18579281 |
|
NCBI chr 7:38,553,055...38,607,239
Ensembl chr 7:38,553,196...38,607,239
|
|
G |
Snx7 |
sorting nexin 7 |
increases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in increased expression of SNX7 mRNA |
CTD |
PMID:18579281 |
|
NCBI chr 2:205,843,164...205,927,737
Ensembl chr 2:205,842,837...205,927,763
|
|
G |
Spon2 |
spondin 2 |
increases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in increased expression of SPON2 mRNA |
CTD |
PMID:18579281 |
|
NCBI chr14:77,505,695...77,518,001
Ensembl chr14:77,511,901...77,517,996
|
|
G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
increases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in increased expression of SREBF1 mRNA |
CTD |
PMID:18579281 |
|
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
|
|
G |
Svil |
supervillin |
increases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in increased expression of SVIL mRNA |
CTD |
PMID:18579281 |
|
NCBI chr17:52,648,502...52,844,114
Ensembl chr17:52,648,502...52,793,404
|
|
G |
Tacc2 |
transforming, acidic coiled-coil containing protein 2 |
decreases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in decreased expression of TACC2 mRNA |
CTD |
PMID:18579281 |
|
NCBI chr 1:185,139,223...185,327,881
Ensembl chr 1:185,116,111...185,327,881
|
|
G |
Tbc1d8 |
TBC1 domain family, member 8 |
decreases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in decreased expression of TBC1D8 mRNA |
CTD |
PMID:18579281 |
|
NCBI chr 9:41,651,394...41,761,432
Ensembl chr 9:41,651,395...41,761,409
|
|
G |
Tcea2 |
transcription elongation factor A2 |
decreases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in decreased expression of TCEA2 mRNA |
CTD |
PMID:18579281 |
|
NCBI chr 3:168,796,244...168,804,125
Ensembl chr 3:168,796,331...168,804,116
|
|
G |
Thra |
thyroid hormone receptor alpha |
increases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in increased expression of THRA mRNA |
CTD |
PMID:18579281 |
|
NCBI chr10:83,701,885...83,729,408
Ensembl chr10:83,700,755...83,729,936
|
|
G |
Thrb |
thyroid hormone receptor beta |
affects binding |
ISO |
2,4,5-Trichlorophenoxyacetic Acid binds to THRB protein |
CTD |
PMID:27410513 |
|
NCBI chr15:7,685,180...8,031,920
Ensembl chr15:7,685,180...7,882,916
|
|
G |
Tom1l2 |
target of myb1 like 2 membrane trafficking protein |
decreases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in decreased expression of TOM1L2 mRNA |
CTD |
PMID:18579281 |
|
NCBI chr10:45,036,034...45,158,168
Ensembl chr10:45,036,035...45,158,032
|
|
G |
Trib3 |
tribbles pseudokinase 3 |
increases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in increased expression of TRIB3 mRNA |
CTD |
PMID:18579281 |
|
NCBI chr 3:140,809,634...140,815,230
Ensembl chr 3:140,809,043...140,814,497
|
|
G |
Tril |
TLR4 interactor with leucine-rich repeats |
decreases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in decreased expression of TRIL mRNA |
CTD |
PMID:18579281 |
|
NCBI chr 4:82,922,327...82,927,172
Ensembl chr 4:82,922,328...82,927,172
|
|
G |
Tsc22d1 |
TSC22 domain family, member 1 |
increases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in increased expression of TSC22D1 mRNA |
CTD |
PMID:18579281 |
|
NCBI chr15:51,750,489...51,850,958
Ensembl chr15:51,749,510...51,850,958
|
|
G |
Ugt2a3 |
UDP glucuronosyltransferase family 2 member A3 |
increases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in increased expression of UGT2A3 mRNA |
CTD |
PMID:18579281 |
|
NCBI chr14:20,572,793...20,590,795
Ensembl chr14:20,572,808...20,590,729
|
|
G |
Usp2 |
ubiquitin specific peptidase 2 |
decreases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in decreased expression of USP2 mRNA |
CTD |
PMID:18579281 |
|
NCBI chr 8:44,411,457...44,439,668
Ensembl chr 8:44,411,607...44,438,331
|
|
G |
Vamp1 |
vesicle-associated membrane protein 1 |
decreases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in decreased expression of VAMP1 mRNA |
CTD |
PMID:18579281 |
|
NCBI chr 4:158,012,634...158,019,350
Ensembl chr 4:158,012,663...158,019,349
|
|
G |
Vcam1 |
vascular cell adhesion molecule 1 |
decreases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in decreased expression of VCAM1 mRNA |
CTD |
PMID:18579281 |
|
NCBI chr 2:204,038,120...204,057,852
Ensembl chr 2:204,038,114...204,057,958
|
|
G |
Veph1 |
ventricular zone expressed PH domain-containing 1 |
increases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in increased expression of VEPH1 mRNA |
CTD |
PMID:18579281 |
|
NCBI chr 2:150,291,379...150,537,491
Ensembl chr 2:150,296,573...150,537,266
|
|
G |
Wars2 |
tryptophanyl tRNA synthetase 2 (mitochondrial) |
increases expression |
ISO |
2,4,5-Trichlorophenoxyacetic Acid results in increased expression of WARS2 mRNA |
CTD |
PMID:18579281 |
|
NCBI chr 2:186,459,744...186,543,581
Ensembl chr 2:186,459,444...186,543,571
|
|
|
G |
Abcb4 |
ATP binding cassette subfamily B member 4 |
increases expression multiple interactions |
ISO |
2,4-Dichlorophenoxyacetic Acid results in increased expression of ABCB4 mRNA [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of ABCB4 mRNA |
CTD |
PMID:9210621 PMID:37567420 |
|
NCBI chr 4:25,150,998...25,209,489
Ensembl chr 4:25,151,953...25,209,202
|
|
G |
Acot1 |
acyl-CoA thioesterase 1 |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of ACOT1 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr 6:103,636,173...103,644,167
Ensembl chr 6:103,636,041...103,644,163
|
|
G |
Adgrf4 |
adhesion G protein-coupled receptor F4 |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of ADGRF4 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr 9:18,272,050...18,303,219
Ensembl chr 9:18,272,050...18,303,217
|
|
G |
Alb |
albumin |
affects binding |
ISO |
2,4-Dichlorophenoxyacetic Acid binds to ALB protein |
CTD |
PMID:9877224 PMID:11451446 |
|
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Aldh1l2 |
aldehyde dehydrogenase 1 family, member L2 |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of ALDH1L2 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr 7:20,254,246...20,305,793
Ensembl chr 7:20,254,233...20,305,776
|
|
G |
Aldh3b3 |
aldehyde dehydrogenase 3 family, member B3 |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of ALDH3B3 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr 1:201,193,832...201,201,666
Ensembl chr 1:201,187,962...201,250,204
|
|
G |
Alpk3 |
alpha-kinase 3 |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of ALPK3 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr 1:135,014,455...135,062,294
Ensembl chr 1:135,014,499...135,062,302
|
|
G |
Aoc1 |
amine oxidase, copper containing 1 |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of AOC1 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr 4:77,812,260...77,831,846
Ensembl chr 4:77,812,260...77,831,840
|
|
G |
Apaf1 |
apoptotic peptidase activating factor 1 |
multiple interactions decreases expression |
ISO |
[Lipopolysaccharides co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of APAF1 mRNA; [Lipopolysaccharides co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of APAF1 protein 2,4-Dichlorophenoxyacetic Acid results in decreased expression of APAF1 mRNA; 2,4-Dichlorophenoxyacetic Acid results in decreased expression of APAF1 protein |
CTD |
PMID:33865415 |
|
NCBI chr 7:25,494,143...25,579,540
Ensembl chr 7:25,494,609...25,579,540
|
|
G |
Ar |
androgen receptor |
multiple interactions |
ISO |
2,4-Dichlorophenoxyacetic Acid inhibits the reaction [Androgens binds to AR protein]; 2,4-Dichlorophenoxyacetic Acid promotes the reaction [Dihydrotestosterone results in increased localization of and results in increased activity of AR protein] [2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate co-treated with lard co-treated with Cholesterol co-treated with Glucose co-treated with Sucrose co-treated with Fructose] results in decreased expression of AR protein; [Sucrose co-treated with Dietary Fats co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of AR mRNA |
CTD |
PMID:16107550 PMID:37516258 PMID:37615203 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Aspg |
asparaginase |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of ASPG mRNA |
CTD |
PMID:37567420 |
|
NCBI chr 6:131,176,727...131,196,268
Ensembl chr 6:131,176,874...131,196,268
|
|
G |
Axin2 |
axin 2 |
multiple interactions increases expression |
ISO |
[Lipopolysaccharides co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of AXIN2 mRNA 2,4-Dichlorophenoxyacetic Acid results in increased expression of AXIN2 mRNA; 2,4-Dichlorophenoxyacetic Acid results in increased expression of AXIN2 protein |
CTD |
PMID:34463001 |
|
NCBI chr10:93,893,830...93,927,042
Ensembl chr10:93,899,245...93,926,231
|
|
G |
Becn1 |
beclin 1 |
multiple interactions decreases expression |
EXP ISO |
lycium barbarum polysaccharide inhibits the reaction [2,4-Dichlorophenoxyacetic Acid results in decreased expression of BECN1 protein] lycium barbarum polysaccharide inhibits the reaction [2,4-Dichlorophenoxyacetic Acid results in decreased expression of BECN1 protein]; NLRP3 protein promotes the reaction [2,4-Dichlorophenoxyacetic Acid results in decreased expression of BECN1 mRNA]; NLRP3 protein promotes the reaction [2,4-Dichlorophenoxyacetic Acid results in decreased expression of BECN1 protein] |
CTD |
PMID:34464015 PMID:35099110 |
|
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
|
|
G |
Cacna1s |
calcium voltage-gated channel subunit alpha1 S |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of CACNA1S mRNA |
CTD |
PMID:37567420 |
|
NCBI chr13:47,493,949...47,564,194
Ensembl chr13:47,493,949...47,564,318
|
|
G |
Casp1 |
caspase 1 |
decreases cleavage multiple interactions increases cleavage |
EXP ISO |
2,4-Dichlorophenoxyacetic Acid results in decreased cleavage of CASP1 protein lycium barbarum polysaccharide inhibits the reaction [2,4-Dichlorophenoxyacetic Acid results in increased cleavage of CASP1 protein] |
CTD |
PMID:34464015 PMID:35099110 |
|
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
|
|
G |
Casp3 |
caspase 3 |
increases expression multiple interactions |
EXP ISO |
2,4-Dichlorophenoxyacetic Acid results in increased expression of CASP3 protein; 2,4-Dichlorophenoxyacetic Acid results in increased expression of CASP3 protein modified form 2,4-Dichlorophenoxyacetic Acid inhibits the reaction [[Sucrose co-treated with Dietary Fats] results in increased expression of CASP3 mRNA]; FAS protein promotes the reaction [2,4-Dichlorophenoxyacetic Acid results in increased expression of CASP3 protein modified form]; FAS protein promotes the reaction [2,4-Dichlorophenoxyacetic Acid results in increased expression of CASP3 protein]; lycium barbarum polysaccharide inhibits the reaction [2,4-Dichlorophenoxyacetic Acid results in increased expression of CASP3 protein modified form]; lycium barbarum polysaccharide inhibits the reaction [2,4-Dichlorophenoxyacetic Acid results in increased expression of CASP3 protein] [2,4-dichlorophenoxyacetic acid isooctyl ester results in increased abundance of 2,4-Dichlorophenoxyacetic Acid] promotes the reaction [Ethanol results in increased expression of CASP3 mRNA]; [2,4-dichlorophenoxyacetic acid isooctyl ester results in increased abundance of 2,4-Dichlorophenoxyacetic Acid] which results in increased expression of CASP3 mRNA; Ethanol promotes the reaction [[2,4-dichlorophenoxyacetic acid isooctyl ester results in increased abundance of 2,4-Dichlorophenoxyacetic Acid] which results in increased expression of CASP3 mRNA]; lycium barbarum polysaccharide inhibits the reaction [2,4-Dichlorophenoxyacetic Acid results in increased expression of CASP3 protein modified form]; lycium barbarum polysaccharide inhibits the reaction [2,4-Dichlorophenoxyacetic Acid results in increased expression of CASP3 protein] |
CTD |
PMID:36085217 PMID:36214342 PMID:37516258 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp8 |
caspase 8 |
increases expression multiple interactions |
ISO EXP |
2,4-Dichlorophenoxyacetic Acid results in increased expression of CASP8 protein; 2,4-Dichlorophenoxyacetic Acid results in increased expression of CASP8 protein modified form FAS protein promotes the reaction [2,4-Dichlorophenoxyacetic Acid results in increased expression of CASP8 protein modified form]; FAS protein promotes the reaction [2,4-Dichlorophenoxyacetic Acid results in increased expression of CASP8 protein]; lycium barbarum polysaccharide inhibits the reaction [2,4-Dichlorophenoxyacetic Acid results in increased expression of CASP8 protein modified form]; lycium barbarum polysaccharide inhibits the reaction [2,4-Dichlorophenoxyacetic Acid results in increased expression of CASP8 protein] [2,4-dichlorophenoxyacetic acid isooctyl ester results in increased abundance of 2,4-Dichlorophenoxyacetic Acid] affects the reaction [Ethanol results in increased expression of CASP8 mRNA]; [2,4-dichlorophenoxyacetic acid isooctyl ester results in increased abundance of 2,4-Dichlorophenoxyacetic Acid] which results in increased expression of CASP8 mRNA; Ethanol affects the reaction [[2,4-dichlorophenoxyacetic acid isooctyl ester results in increased abundance of 2,4-Dichlorophenoxyacetic Acid] which results in increased expression of CASP8 mRNA]; lycium barbarum polysaccharide inhibits the reaction [2,4-Dichlorophenoxyacetic Acid results in increased expression of CASP8 protein modified form]; lycium barbarum polysaccharide inhibits the reaction [2,4-Dichlorophenoxyacetic Acid results in increased expression of CASP8 protein] |
CTD |
PMID:36085217 PMID:36214342 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
multiple interactions |
EXP |
[2,4-dichlorophenoxyacetic acid isooctyl ester results in increased abundance of 2,4-Dichlorophenoxyacetic Acid] promotes the reaction [Ethanol results in increased expression of CASP9 mRNA]; [2,4-dichlorophenoxyacetic acid isooctyl ester results in increased abundance of 2,4-Dichlorophenoxyacetic Acid] which results in increased expression of CASP9 mRNA; Ethanol promotes the reaction [[2,4-dichlorophenoxyacetic acid isooctyl ester results in increased abundance of 2,4-Dichlorophenoxyacetic Acid] which results in increased expression of CASP9 mRNA] |
CTD |
PMID:36085217 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
multiple interactions |
EXP ISO |
[2,4-dichlorophenoxyacetic acid isooctyl ester results in increased abundance of 2,4-Dichlorophenoxyacetic Acid] promotes the reaction [Ethanol results in decreased activity of CAT protein]; [2,4-dichlorophenoxyacetic acid isooctyl ester results in increased abundance of 2,4-Dichlorophenoxyacetic Acid] which results in decreased activity of CAT protein; Ethanol promotes the reaction [[2,4-dichlorophenoxyacetic acid isooctyl ester results in increased abundance of 2,4-Dichlorophenoxyacetic Acid] which results in decreased activity of CAT protein] 2,4-Dichlorophenoxyacetic Acid inhibits the reaction [[Sucrose co-treated with Dietary Fats] results in increased expression of CAT mRNA] |
CTD |
PMID:36085217 PMID:37516258 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccdc120 |
coiled-coil domain containing 120 |
decreases expression |
ISO |
2,4-Dichlorophenoxyacetic Acid results in decreased expression of CCDC120 mRNA |
CTD |
PMID:15878651 |
|
NCBI chr X:14,753,594...14,772,745
Ensembl chr X:14,753,696...14,772,743
|
|
G |
Ccl11 |
C-C motif chemokine ligand 11 |
increases expression |
ISO |
2,4-Dichlorophenoxyacetic Acid results in increased expression of CCL11 protein |
CTD |
PMID:19467290 |
|
NCBI chr10:67,028,328...67,032,929
Ensembl chr10:67,028,328...67,032,926
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
increases expression multiple interactions |
ISO EXP |
2,4-Dichlorophenoxyacetic Acid results in increased expression of CCL2 protein [2,4-dichlorophenoxyacetic acid isooctyl ester results in increased abundance of 2,4-Dichlorophenoxyacetic Acid] affects the reaction [Ethanol results in increased expression of CCL2 mRNA]; [2,4-dichlorophenoxyacetic acid isooctyl ester results in increased abundance of 2,4-Dichlorophenoxyacetic Acid] which results in increased expression of CCL2 mRNA; Ethanol promotes the reaction [[2,4-dichlorophenoxyacetic acid isooctyl ester results in increased abundance of 2,4-Dichlorophenoxyacetic Acid] which results in increased expression of CCL2 mRNA] |
CTD |
PMID:19467290 PMID:36085217 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccl4 |
C-C motif chemokine ligand 4 |
increases expression |
ISO |
2,4-Dichlorophenoxyacetic Acid results in increased expression of CCL4 protein |
CTD |
PMID:19467290 |
|
NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,452,052...68,468,231
|
|
G |
Cd40lg |
CD40 ligand |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of CD40LG mRNA |
CTD |
PMID:37567420 |
|
NCBI chr X:135,127,052...135,138,768
Ensembl chr X:135,126,969...135,138,306
|
|
G |
Cd5 |
Cd5 molecule |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of CD5 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr 1:207,365,337...207,386,313
Ensembl chr 1:207,365,337...207,386,313
|
|
G |
Cdk6 |
cyclin-dependent kinase 6 |
increases expression multiple interactions |
ISO |
2,4-Dichlorophenoxyacetic Acid results in increased expression of CDK6 mRNA; 2,4-Dichlorophenoxyacetic Acid results in increased expression of CDK6 protein [Lipopolysaccharides co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of CDK6 mRNA; [Lipopolysaccharides co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of CDK6 protein |
CTD |
PMID:33865415 |
|
NCBI chr 4:30,637,650...30,829,688
Ensembl chr 4:30,646,460...30,829,634
|
|
G |
Celsr3 |
cadherin, EGF LAG seven-pass G-type receptor 3 |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of CELSR3 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr 8:109,530,597...109,558,360
Ensembl chr 8:109,530,641...109,558,354
|
|
G |
Cimap1c |
ciliary microtubule associated protein 1C |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of CIMAP1C mRNA |
CTD |
PMID:37567420 |
|
NCBI chr 8:57,248,746...57,281,084
Ensembl chr 8:57,248,746...57,281,004
|
|
G |
Cldn1 |
claudin 1 |
decreases expression |
EXP |
2,4-Dichlorophenoxyacetic Acid results in decreased expression of CLDN1 mRNA; 2,4-Dichlorophenoxyacetic Acid results in decreased expression of CLDN1 protein |
CTD |
PMID:28699141 |
|
NCBI chr11:74,421,569...74,436,728
Ensembl chr11:74,421,569...74,436,724
|
|
G |
Clk1 |
CDC-like kinase 1 |
decreases expression |
ISO |
2,4-Dichlorophenoxyacetic Acid results in decreased expression of CLK1 mRNA |
CTD |
PMID:15878651 |
|
NCBI chr 9:59,947,774...59,959,002
Ensembl chr 9:59,947,764...59,957,000
|
|
G |
Cnp |
2',3'-cyclic nucleotide 3' phosphodiesterase |
decreases expression |
EXP |
2,4-Dichlorophenoxyacetic Acid results in decreased expression of CNP protein |
CTD |
PMID:18460445 |
|
NCBI chr10:85,511,164...85,517,723
Ensembl chr10:85,511,160...85,517,720
|
|
G |
Cntnap2 |
contactin associated protein 2 |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of CNTNAP2 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr 4:74,109,455...76,366,434
Ensembl chr 4:74,109,472...76,362,027
|
|
G |
Col6a5 |
collagen type VI alpha 5 chain |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of COL6A5 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr 8:106,483,806...106,584,114
Ensembl chr 8:106,483,799...106,584,113
|
|
G |
Col6a6 |
collagen type VI alpha 6 chain |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of COL6A6 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr 8:106,318,010...106,473,419
Ensembl chr 8:106,306,422...106,473,472
|
|
G |
Crat |
carnitine O-acetyltransferase |
increases activity |
ISO |
2,4-Dichlorophenoxyacetic Acid results in increased activity of CRAT protein |
CTD |
PMID:1755024 |
|
NCBI chr 3:13,675,684...13,689,282
Ensembl chr 3:13,675,684...13,689,255
|
|
G |
Creb1 |
cAMP responsive element binding protein 1 |
increases expression multiple interactions |
ISO |
2,4-Dichlorophenoxyacetic Acid results in increased expression of CREB1 mRNA; 2,4-Dichlorophenoxyacetic Acid results in increased expression of CREB1 protein PPARB protein affects the reaction [2,4-Dichlorophenoxyacetic Acid results in increased expression of CREB1 mRNA] |
CTD |
PMID:29633193 |
|
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
|
|
G |
Creb3l3 |
cAMP responsive element binding protein 3-like 3 |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of CREB3L3 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr 7:8,622,614...8,631,053
Ensembl chr 7:8,622,614...8,631,048
|
|
G |
Cst6 |
cystatin E/M |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of CST6 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr 1:202,655,322...202,657,030
Ensembl chr 1:202,655,322...202,657,030
|
|
G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
affects expression |
ISO |
2,4-Dichlorophenoxyacetic Acid affects the expression of CYP17A1 mRNA |
CTD |
PMID:26838045 |
|
NCBI chr 1:245,535,462...245,543,148
Ensembl chr 1:245,535,462...245,541,573
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases expression |
EXP |
2,4-Dichlorophenoxyacetic Acid results in increased expression of CYP1A1 mRNA |
CTD |
PMID:10910964 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
increases expression |
EXP |
2,4-Dichlorophenoxyacetic Acid results in increased expression of CYP1A2 mRNA |
CTD |
PMID:10910964 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
increases expression |
EXP |
2,4-Dichlorophenoxyacetic Acid results in increased expression of CYP1B1 mRNA |
CTD |
PMID:10910964 |
|
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Cyp26b1 |
cytochrome P450, family 26, subfamily b, polypeptide 1 |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of CYP26B1 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr 4:117,041,808...117,058,628
Ensembl chr 4:117,041,808...117,058,628
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
multiple interactions |
EXP |
[2,4-dichlorophenoxyacetic acid isooctyl ester results in increased abundance of 2,4-Dichlorophenoxyacetic Acid] promotes the reaction [Ethanol results in increased expression of CYP2E1 mRNA]; [2,4-dichlorophenoxyacetic acid isooctyl ester results in increased abundance of 2,4-Dichlorophenoxyacetic Acid] which results in increased expression of CYP2E1 mRNA; Ethanol promotes the reaction [[2,4-dichlorophenoxyacetic acid isooctyl ester results in increased abundance of 2,4-Dichlorophenoxyacetic Acid] which results in increased expression of CYP2E1 mRNA] |
CTD |
PMID:36085217 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Dbh |
dopamine beta-hydroxylase |
decreases expression |
EXP |
2,4-Dichlorophenoxyacetic Acid results in decreased expression of DBH protein |
CTD |
PMID:16931444 |
|
NCBI chr 3:10,488,260...10,505,245
Ensembl chr 3:10,488,260...10,505,248
|
|
G |
Dbp |
D-box binding PAR bZIP transcription factor |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of DBP mRNA |
CTD |
PMID:37567420 |
|
NCBI chr 1:96,175,796...96,180,745
Ensembl chr 1:96,175,440...96,180,745
|
|
G |
Dclre1c |
DNA cross-link repair 1C |
increases expression |
ISO |
2,4-Dichlorophenoxyacetic Acid results in increased expression of DCLRE1C mRNA |
CTD |
PMID:15878651 |
|
NCBI chr17:74,775,828...74,810,089
Ensembl chr17:74,776,935...74,809,186
|
|
G |
Ddb2 |
damage specific DNA binding protein 2 |
increases expression |
ISO |
2,4-Dichlorophenoxyacetic Acid results in increased expression of DDB2 mRNA |
CTD |
PMID:15878651 |
|
NCBI chr 3:77,185,114...77,207,650
Ensembl chr 3:77,185,109...77,207,631
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
increases expression |
ISO |
2,4-Dichlorophenoxyacetic Acid results in increased expression of DDIT3 mRNA |
CTD |
PMID:34626751 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Dicer1 |
dicer 1 ribonuclease III |
multiple interactions |
ISO |
2,4-Dichlorophenoxyacetic Acid inhibits the reaction [[Sucrose co-treated with Dietary Fats] results in increased expression of DICER1 mRNA] |
CTD |
PMID:37516258 |
|
NCBI chr 6:123,627,529...123,692,278
Ensembl chr 6:123,631,250...123,693,965
|
|
G |
Dnmt1 |
DNA methyltransferase 1 |
multiple interactions |
ISO |
2,4-Dichlorophenoxyacetic Acid inhibits the reaction [[Sucrose co-treated with Dietary Fats] results in increased expression of DNMT1 mRNA] |
CTD |
PMID:37516258 |
|
NCBI chr 8:19,440,611...19,486,659
Ensembl chr 8:19,440,611...19,486,659
|
|
G |
Dok7 |
docking protein 7 |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of DOK7 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr14:75,665,444...75,699,413
Ensembl chr14:75,666,744...75,699,386
|
|
G |
Drosha |
drosha ribonuclease III |
multiple interactions |
ISO |
2,4-Dichlorophenoxyacetic Acid inhibits the reaction [[Sucrose co-treated with Dietary Fats] results in increased expression of DROSHA mRNA] |
CTD |
PMID:37516258 |
|
NCBI chr 2:61,864,886...61,976,688
Ensembl chr 2:61,864,970...61,976,688
|
|
G |
Dusp5 |
dual specificity phosphatase 5 |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of DUSP5 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr 1:252,538,408...252,555,320
Ensembl chr 1:252,538,449...252,551,818
|
|
G |
Ebln1 |
endogenous Bornavirus like nucleoprotein 1 |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of IGKV8-24 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr10:78,938,645...78,940,651
|
|
G |
Ephx1 |
epoxide hydrolase 1 |
increases activity |
ISO |
2,4-Dichlorophenoxyacetic Acid results in increased activity of EPHX1 protein |
CTD |
PMID:3032197 |
|
NCBI chr13:92,714,315...92,744,105
Ensembl chr13:92,714,315...92,790,235
|
|
G |
Ephx2 |
epoxide hydrolase 2 |
increases activity |
ISO |
2,4-Dichlorophenoxyacetic Acid results in increased activity of EPHX2 protein |
CTD |
PMID:1755024 PMID:3032197 |
|
NCBI chr15:40,289,901...40,327,632
Ensembl chr15:40,289,902...40,327,615
|
|
G |
Fadd |
Fas associated via death domain |
increases expression multiple interactions |
EXP ISO |
2,4-Dichlorophenoxyacetic Acid results in increased expression of FADD protein lycium barbarum polysaccharide inhibits the reaction [2,4-Dichlorophenoxyacetic Acid results in increased expression of FADD protein] FAS protein promotes the reaction [2,4-Dichlorophenoxyacetic Acid results in increased expression of FADD protein]; lycium barbarum polysaccharide inhibits the reaction [2,4-Dichlorophenoxyacetic Acid results in increased expression of FADD protein] |
CTD |
PMID:36214342 |
|
NCBI chr 1:199,743,200...199,745,746
Ensembl chr 1:199,739,994...199,745,653
|
|
G |
Fam163a |
family with sequence similarity 163, member A |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of FAM163A mRNA |
CTD |
PMID:37567420 |
|
NCBI chr13:68,262,867...68,341,323
Ensembl chr13:68,262,872...68,341,049
|
|
G |
Fas |
Fas cell surface death receptor |
multiple interactions increases response to substance increases expression |
ISO EXP |
FAS protein promotes the reaction [2,4-Dichlorophenoxyacetic Acid results in decreased secretion of INHBB protein]; FAS protein promotes the reaction [2,4-Dichlorophenoxyacetic Acid results in increased expression of CASP3 protein modified form]; FAS protein promotes the reaction [2,4-Dichlorophenoxyacetic Acid results in increased expression of CASP3 protein]; FAS protein promotes the reaction [2,4-Dichlorophenoxyacetic Acid results in increased expression of CASP8 protein modified form]; FAS protein promotes the reaction [2,4-Dichlorophenoxyacetic Acid results in increased expression of CASP8 protein]; FAS protein promotes the reaction [2,4-Dichlorophenoxyacetic Acid results in increased expression of FADD protein]; FAS protein promotes the reaction [2,4-Dichlorophenoxyacetic Acid results in increased expression of FASL protein]; lycium barbarum polysaccharide inhibits the reaction [2,4-Dichlorophenoxyacetic Acid results in increased expression of FAS protein] FAS protein results in increased susceptibility to 2,4-Dichlorophenoxyacetic Acid |
CTD |
PMID:36214342 |
|
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Faslg |
Fas ligand |
increases expression multiple interactions |
EXP ISO |
2,4-Dichlorophenoxyacetic Acid results in increased expression of FASLG protein lycium barbarum polysaccharide inhibits the reaction [2,4-Dichlorophenoxyacetic Acid results in increased expression of FASLG protein] FAS protein promotes the reaction [2,4-Dichlorophenoxyacetic Acid results in increased expression of FASL protein]; lycium barbarum polysaccharide inhibits the reaction [2,4-Dichlorophenoxyacetic Acid results in increased expression of FASL protein] |
CTD |
PMID:36214342 |
|
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
|
|
G |
Fbxo48 |
F-box protein 48 |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of FBXO48 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr14:91,380,857...91,382,314
Ensembl chr14:91,380,857...91,382,314
|
|
G |
Fendrr |
FOXF1 adjacent non-coding developmental regulatory RNA |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of FENDRR mRNA |
CTD |
PMID:37567420 |
|
NCBI chr19:49,127,225...49,152,780
Ensembl chr19:49,121,214...49,153,240
|
|
G |
Ffar3 |
free fatty acid receptor 3 |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of FFAR3 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr 1:86,105,388...86,106,728
Ensembl chr 1:86,104,920...86,106,849
|
|
G |
Fhad1 |
forkhead associated phosphopeptide binding domain 1 |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of FHAD1 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr 5:154,191,593...154,310,442
Ensembl chr 5:154,191,745...154,310,354
|
|
G |
Flg |
filaggrin |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of FLG mRNA |
CTD |
PMID:37567420 |
|
NCBI chr 2:178,884,793...178,912,986
|
|
G |
Foxo1 |
forkhead box O1 |
multiple interactions increases expression |
ISO |
PPARB protein affects the reaction [2,4-Dichlorophenoxyacetic Acid results in increased expression of FOXO1 mRNA] 2,4-Dichlorophenoxyacetic Acid results in increased expression of FOXO1 mRNA; 2,4-Dichlorophenoxyacetic Acid results in increased expression of FOXO1 protein |
CTD |
PMID:29633193 |
|
NCBI chr 2:136,312,168...136,390,603
Ensembl chr 2:136,312,168...136,387,790
|
|
G |
Fth1 |
ferritin heavy chain 1 |
increases expression |
ISO |
2,4-Dichlorophenoxyacetic Acid results in increased expression of FTH1 mRNA |
CTD |
PMID:15878651 |
|
NCBI chr 1:206,627,142...206,629,430
Ensembl chr 1:206,627,103...206,725,424
|
|
G |
Ftl1 |
ferritin light chain 1 |
increases expression |
ISO |
2,4-Dichlorophenoxyacetic Acid results in increased expression of FTL mRNA |
CTD |
PMID:15878651 |
|
NCBI chr 1:95,936,387...95,938,234
Ensembl chr 1:95,936,387...95,939,725 Ensembl chr10:95,936,387...95,939,725
|
|
G |
Galnt16 |
polypeptide N-acetylgalactosaminyltransferase 16 |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of GALNT16 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr 6:100,168,943...100,250,718
Ensembl chr 6:100,170,306...100,250,705
|
|
G |
Galnt2 |
polypeptide N-acetylgalactosaminyltransferase 2 |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of GALNT2 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr19:52,213,226...52,324,816
Ensembl chr19:52,213,351...52,324,813
|
|
G |
Gcsam |
germinal center-associated, signaling and motility |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of GCSAM mRNA |
CTD |
PMID:37567420 |
|
NCBI chr11:55,195,757...55,207,011
Ensembl chr11:55,196,712...55,206,992
|
|
G |
Gfap |
glial fibrillary acidic protein |
increases expression |
EXP |
2,4-Dichlorophenoxyacetic Acid results in increased expression of GFAP mRNA |
CTD |
PMID:22954530 |
|
NCBI chr10:87,852,891...87,861,631
Ensembl chr10:87,852,890...87,861,589
|
|
G |
Gli2 |
GLI family zinc finger 2 |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of GLI2 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr13:29,946,882...30,163,589
Ensembl chr13:29,946,809...30,163,574
|
|
G |
Gna15 |
G protein subunit alpha 15 |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of GNA15 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr 7:8,184,632...8,205,508
Ensembl chr 7:8,184,861...8,205,508
|
|
G |
Golt1a |
golgi transport 1A |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of GOLT1A mRNA |
CTD |
PMID:37567420 |
|
NCBI chr13:44,760,356...44,773,123
Ensembl chr13:44,760,380...44,773,122
|
|
G |
Gp5 |
glycoprotein V (platelet) |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of GP5 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr11:70,443,613...70,446,705
Ensembl chr11:70,443,613...70,446,705
|
|
G |
Gp6 |
glycoprotein VI |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of GP6 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr 1:69,429,232...69,492,709
Ensembl chr 1:69,465,789...69,491,326
|
|
G |
Gpr151 |
G protein-coupled receptor 151 |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of GPR151 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr18:34,568,907...34,570,301
Ensembl chr18:34,568,907...34,570,301
|
|
G |
Gpr171 |
G protein-coupled receptor 171 |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of GPR171 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr 2:143,360,402...143,365,494
Ensembl chr 2:143,359,564...143,366,698
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
multiple interactions |
EXP |
[2,4-dichlorophenoxyacetic acid isooctyl ester results in increased abundance of 2,4-Dichlorophenoxyacetic Acid] promotes the reaction [Ethanol results in increased expression of GPT protein]; [2,4-dichlorophenoxyacetic acid isooctyl ester results in increased abundance of 2,4-Dichlorophenoxyacetic Acid] which results in increased expression of GPT protein; Ethanol promotes the reaction [[2,4-dichlorophenoxyacetic acid isooctyl ester results in increased abundance of 2,4-Dichlorophenoxyacetic Acid] which results in increased expression of GPT protein] |
CTD |
PMID:36085217 |
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
decreases activity |
ISO |
2,4-Dichlorophenoxyacetic Acid results in decreased activity of GPX1 protein |
CTD |
PMID:35099110 |
|
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
|
|
G |
Gsr |
glutathione-disulfide reductase |
multiple interactions |
ISO |
2,4-Dichlorophenoxyacetic Acid inhibits the reaction [[Sucrose co-treated with Dietary Fats] results in increased expression of GSR mRNA] |
CTD |
PMID:37516258 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Gucy2e |
guanylate cyclase 2E |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of GUCY2E mRNA |
CTD |
PMID:37567420 |
|
NCBI chr10:53,954,918...53,975,576
Ensembl chr10:53,959,010...53,974,067
|
|
G |
Hamp |
hepcidin antimicrobial peptide |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of HAMP mRNA |
CTD |
PMID:37567420 |
|
NCBI chr 1:86,170,926...86,172,865
Ensembl chr 1:86,170,901...86,172,891
|
|
G |
Hapln1 |
hyaluronan and proteoglycan link protein 1 |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of HAPLN1 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr 2:20,631,640...20,696,388
Ensembl chr 2:20,631,640...20,693,777
|
|
G |
Hcrt |
hypocretin neuropeptide precursor |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of HCRT mRNA |
CTD |
PMID:37567420 |
|
NCBI chr10:85,689,979...85,691,214
Ensembl chr10:85,689,465...85,691,210
|
|
G |
Hhipl1 |
HHIP-like 1 |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of HHIPL1 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr 6:127,219,616...127,243,839
Ensembl chr 6:127,220,014...127,242,564
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
decreases expression |
ISO |
2,4-Dichlorophenoxyacetic Acid results in decreased expression of HMGCR |
CTD |
PMID:26838045 |
|
NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
|
|
G |
Hmgcs1 |
3-hydroxy-3-methylglutaryl-CoA synthase 1 |
decreases expression |
ISO |
2,4-Dichlorophenoxyacetic Acid results in decreased expression of HMGCS1 |
CTD |
PMID:26838045 |
|
NCBI chr 2:51,649,368...51,667,100
Ensembl chr 2:51,649,497...51,667,100
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of HMOX1 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hsf2bp |
heat shock transcription factor 2 binding protein |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of HSF2BP mRNA |
CTD |
PMID:37567420 |
|
NCBI chr20:10,035,562...10,123,059
Ensembl chr20:10,035,562...10,121,242
|
|
G |
Ifng |
interferon gamma |
increases expression |
ISO |
2,4-Dichlorophenoxyacetic Acid results in increased expression of IFNG |
CTD |
PMID:20728597 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Igfn1 |
immunoglobulin-like and fibronectin type III domain containing 1 |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of IGFN1 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr13:47,395,618...47,427,506
Ensembl chr13:47,395,595...47,437,879
|
|
G |
Igkvl-ps13 |
immunoglobulin kappa variable like, pseudogene 13 |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of IGKV1-133 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr 4:96,968,574...96,969,477
|
|
G |
Il10 |
interleukin 10 |
multiple interactions |
ISO |
2,4-Dichlorophenoxyacetic Acid inhibits the reaction [[Sucrose co-treated with Dietary Fats] results in increased expression of IL10 mRNA] |
CTD |
PMID:37516258 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il12b |
interleukin 12B |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of IL12B mRNA |
CTD |
PMID:37567420 |
|
NCBI chr10:28,888,832...28,903,802
Ensembl chr10:28,893,008...28,902,903
|
|
G |
Il18 |
interleukin 18 |
increases expression multiple interactions |
EXP ISO |
2,4-Dichlorophenoxyacetic Acid results in increased expression of IL18 mRNA; 2,4-Dichlorophenoxyacetic Acid results in increased expression of IL18 protein lycium barbarum polysaccharide inhibits the reaction [2,4-Dichlorophenoxyacetic Acid results in increased expression of IL18 mRNA]; lycium barbarum polysaccharide inhibits the reaction [2,4-Dichlorophenoxyacetic Acid results in increased expression of IL18 protein]; NLRP3 protein promotes the reaction [2,4-Dichlorophenoxyacetic Acid results in increased expression of IL18 mRNA]; NLRP3 protein promotes the reaction [2,4-Dichlorophenoxyacetic Acid results in increased expression of IL18 protein] |
CTD |
PMID:34464015 PMID:35099110 |
|
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
|
|
G |
Il1b |
interleukin 1 beta |
increases expression multiple interactions |
EXP ISO |
2,4-Dichlorophenoxyacetic Acid results in increased expression of IL1B mRNA; 2,4-Dichlorophenoxyacetic Acid results in increased expression of IL1B protein [aminomethylphosphonic acid (AMPA) co-treated with 2,4-Dichlorophenoxyacetic Acid metabolite co-treated with Ethylenethiourea co-treated with desethylatrazine] results in decreased expression of IL1B protein lycium barbarum polysaccharide inhibits the reaction [2,4-Dichlorophenoxyacetic Acid results in increased expression of IL1B mRNA]; lycium barbarum polysaccharide inhibits the reaction [2,4-Dichlorophenoxyacetic Acid results in increased expression of IL1B protein]; NLRP3 protein promotes the reaction [2,4-Dichlorophenoxyacetic Acid results in increased expression of IL1B mRNA]; NLRP3 protein promotes the reaction [2,4-Dichlorophenoxyacetic Acid results in increased expression of IL1B protein] |
CTD |
PMID:34464015 PMID:35099110 PMID:37236337 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il1rl1 |
interleukin 1 receptor-like 1 |
decreases expression |
ISO |
2,4-Dichlorophenoxyacetic Acid results in decreased expression of IL1RL1 mRNA |
CTD |
PMID:15878651 |
|
NCBI chr 9:42,661,694...42,727,266
Ensembl chr 9:42,697,192...42,727,256
|
|
G |
Il2 |
interleukin 2 |
increases expression |
ISO |
2,4-Dichlorophenoxyacetic Acid results in increased expression of IL2 |
CTD |
PMID:20728597 |
|
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
|
|
G |
Il2ra |
interleukin 2 receptor subunit alpha |
increases expression |
ISO |
2,4-Dichlorophenoxyacetic Acid results in increased expression of IL2RA |
CTD |
PMID:20728597 |
|
NCBI chr17:66,849,974...66,898,665
Ensembl chr17:66,849,974...66,898,697
|
|
G |
Il4 |
interleukin 4 |
increases expression increases secretion |
ISO |
2,4-Dichlorophenoxyacetic Acid results in increased expression of IL4 protein 2,4-Dichlorophenoxyacetic Acid results in increased secretion of IL4 protein |
CTD |
PMID:19467290 |
|
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
|
|
G |
Il5 |
interleukin 5 |
increases expression |
ISO |
2,4-Dichlorophenoxyacetic Acid results in increased expression of IL5 protein |
CTD |
PMID:19467290 |
|
NCBI chr10:37,874,342...37,877,213
Ensembl chr10:37,874,342...37,877,213
|
|
G |
Il6 |
interleukin 6 |
increases expression multiple interactions |
ISO EXP |
2,4-Dichlorophenoxyacetic Acid results in increased expression of IL6 protein 2,4-Dichlorophenoxyacetic Acid inhibits the reaction [[Sucrose co-treated with Dietary Fats] results in increased expression of IL6 mRNA]; lycium barbarum polysaccharide inhibits the reaction [2,4-Dichlorophenoxyacetic Acid results in increased expression of IL6 protein] |
CTD |
PMID:19467290 PMID:34464015 PMID:35099110 PMID:37516258 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Inhbb |
inhibin subunit beta B |
decreases secretion multiple interactions |
ISO |
2,4-Dichlorophenoxyacetic Acid results in decreased secretion of INHBB protein FAS protein promotes the reaction [2,4-Dichlorophenoxyacetic Acid results in decreased secretion of INHBB protein]; lycium barbarum polysaccharide inhibits the reaction [2,4-Dichlorophenoxyacetic Acid results in decreased secretion of INHBB protein] |
CTD |
PMID:36214342 |
|
NCBI chr13:30,530,860...30,536,566
Ensembl chr13:30,530,860...30,537,832
|
|
G |
Islr2 |
immunoglobulin superfamily containing leucine-rich repeat 2 |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of ISLR2 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr 8:58,608,165...58,616,246
Ensembl chr 8:58,608,709...58,614,650
|
|
G |
Ism2 |
isthmin 2 |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of ISM2 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr 6:106,921,213...106,944,291
Ensembl chr 6:106,926,175...106,944,514
|
|
G |
Itgb1 |
integrin subunit beta 1 |
increases expression multiple interactions |
ISO |
2,4-Dichlorophenoxyacetic Acid results in increased expression of ITGB1 mRNA; 2,4-Dichlorophenoxyacetic Acid results in increased expression of ITGB1 protein [Lipopolysaccharides co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of ITGB1 mRNA; [Lipopolysaccharides co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of ITGB1 protein |
CTD |
PMID:33865415 |
|
NCBI chr19:56,705,123...56,753,199
Ensembl chr19:56,705,171...56,753,195
|
|
G |
Kcnip2 |
potassium voltage-gated channel interacting protein 2 |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of KCNIP2 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr 1:244,641,147...244,664,939
Ensembl chr 1:244,641,150...244,664,874
|
|
G |
Kcnma1 |
potassium calcium-activated channel subfamily M alpha 1 |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of KCNMA1 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr15:302,480...1,007,675
Ensembl chr15:302,214...1,001,198
|
|
G |
Krt20 |
keratin 20 |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of KRT20 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr10:84,384,790...84,394,125
Ensembl chr10:84,384,802...84,394,107
|
|
G |
Lax1 |
lymphocyte transmembrane adaptor 1 |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of LAX1 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr13:45,134,825...45,145,381
Ensembl chr13:45,134,834...45,145,381
|
|
G |
Lca5l |
lebercilin LCA5 like |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of LCA5L mRNA |
CTD |
PMID:37567420 |
|
NCBI chr11:35,460,646...35,495,133
Ensembl chr11:35,461,118...35,495,047
|
|
G |
Ldha |
lactate dehydrogenase A |
decreases expression |
EXP |
2,4-Dichlorophenoxyacetic Acid results in decreased expression of LDHA mRNA; 2,4-Dichlorophenoxyacetic Acid results in decreased expression of LDHA protein |
CTD |
PMID:23538319 |
|
NCBI chr 1:97,371,823...97,381,247
Ensembl chr 1:97,366,021...97,433,472
|
|
G |
Lin7b |
lin-7 homolog B, crumbs cell polarity complex component |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of LIN7B mRNA |
CTD |
PMID:37567420 |
|
NCBI chr 1:95,846,888...95,849,628
Ensembl chr 1:95,846,243...95,849,977
|
|
G |
Llcfc1 |
LLLL and CFNLAS motif containing 1 |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of LLCFC1 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr 4:70,566,206...70,567,592
Ensembl chr 4:70,566,295...70,567,586
|
|
G |
Lrch4 |
leucine rich repeats and calponin homology domain containing 4 |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of LRCH4 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr12:19,057,582...19,072,573
Ensembl chr12:19,057,587...19,068,577
|
|
G |
LRRTM1 |
leucine rich repeat transmembrane neuronal 1 |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of LRRTM1 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr 4:109,701,815...109,718,924
Ensembl chr 4:109,701,815...109,717,184
|
|
G |
Maob |
monoamine oxidase B |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of MAOB mRNA |
CTD |
PMID:37567420 |
|
NCBI chr X:5,907,327...6,010,996
Ensembl chr X:5,907,266...6,011,003
|
|
G |
Map1lc3b |
microtubule-associated protein 1 light chain 3 beta |
decreases expression multiple interactions affects localization |
EXP ISO |
2,4-Dichlorophenoxyacetic Acid results in decreased expression of MAP1LC3B mRNA lycium barbarum polysaccharide inhibits the reaction [2,4-Dichlorophenoxyacetic Acid affects the localization of MAP1LC3B protein]; lycium barbarum polysaccharide inhibits the reaction [2,4-Dichlorophenoxyacetic Acid results in decreased expression of MAP1LC3B mRNA]; NLRP3 protein promotes the reaction [2,4-Dichlorophenoxyacetic Acid results in decreased expression of MAP1LC3B mRNA] |
CTD |
PMID:34464015 PMID:35099110 |
|
NCBI chr19:49,665,795...49,673,655
Ensembl chr19:49,665,791...49,677,690
|
|
G |
Mbp |
myelin basic protein |
decreases expression |
EXP |
2,4-Dichlorophenoxyacetic Acid results in decreased expression of MBP protein |
CTD |
PMID:18460445 |
|
NCBI chr18:75,855,878...75,966,404
Ensembl chr18:75,855,878...75,966,404
|
|
G |
Mki67 |
marker of proliferation Ki-67 |
multiple interactions |
ISO |
2,4-Dichlorophenoxyacetic Acid inhibits the reaction [[Sucrose co-treated with Dietary Fats] results in increased expression of MKI67 mRNA] |
CTD |
PMID:37516258 |
|
NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
|
|
G |
Mthfd2 |
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of MTHFD2 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr 4:115,811,135...115,822,663
Ensembl chr 4:115,811,139...115,822,608
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
decreases methylation |
ISO |
2,4-Dichlorophenoxyacetic Acid results in decreased methylation of MYC promoter |
CTD |
PMID:11857776 |
|
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Nanp |
N-acetylneuraminic acid phosphatase |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of NANP mRNA |
CTD |
PMID:37567420 |
|
NCBI chr 3:139,826,549...139,841,655
Ensembl chr 3:139,826,549...139,841,648
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
multiple interactions increases expression |
ISO |
[Lipopolysaccharides co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of NFKB1 mRNA; [Lipopolysaccharides co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of NFKB1 protein 2,4-Dichlorophenoxyacetic Acid results in increased expression of NFKB1 mRNA; 2,4-Dichlorophenoxyacetic Acid results in increased expression of NFKB1 protein |
CTD |
PMID:33865415 |
|
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
|
|
G |
Nlrp3 |
NLR family, pyrin domain containing 3 |
increases expression multiple interactions |
EXP ISO |
2,4-Dichlorophenoxyacetic Acid results in increased expression of NLRP3 mRNA; 2,4-Dichlorophenoxyacetic Acid results in increased expression of NLRP3 protein lycium barbarum polysaccharide inhibits the reaction [2,4-Dichlorophenoxyacetic Acid results in increased expression of NLRP3 protein]; NLRP3 protein promotes the reaction [2,4-Dichlorophenoxyacetic Acid results in decreased expression of BECN1 mRNA]; NLRP3 protein promotes the reaction [2,4-Dichlorophenoxyacetic Acid results in decreased expression of BECN1 protein]; NLRP3 protein promotes the reaction [2,4-Dichlorophenoxyacetic Acid results in decreased expression of MAP1LC3B mRNA]; NLRP3 protein promotes the reaction [2,4-Dichlorophenoxyacetic Acid results in increased expression of IL18 mRNA]; NLRP3 protein promotes the reaction [2,4-Dichlorophenoxyacetic Acid results in increased expression of IL18 protein]; NLRP3 protein promotes the reaction [2,4-Dichlorophenoxyacetic Acid results in increased expression of IL1B mRNA]; NLRP3 protein promotes the reaction [2,4-Dichlorophenoxyacetic Acid results in increased expression of IL1B protein]; NLRP3 protein promotes the reaction [2,4-Dichlorophenoxyacetic Acid results in increased expression of SQSTM1 mRNA]; NLRP3 protein promotes the reaction [2,4-Dichlorophenoxyacetic Acid results in increased expression of SQSTM1 protein] lycium barbarum polysaccharide inhibits the reaction [2,4-Dichlorophenoxyacetic Acid results in increased expression of NLRP3 mRNA]; lycium barbarum polysaccharide inhibits the reaction [2,4-Dichlorophenoxyacetic Acid results in increased expression of NLRP3 protein] |
CTD |
PMID:34464015 PMID:35099110 |
|
NCBI chr10:44,326,770...44,353,814
Ensembl chr10:44,328,566...44,352,811
|
|
G |
Nobox |
NOBOX oogenesis homeobox |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of NOBOX mRNA |
CTD |
PMID:37567420 |
|
NCBI chr 4:72,128,931...72,134,436
Ensembl chr 4:72,128,931...72,134,436
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
multiple interactions |
ISO |
2,4-Dichlorophenoxyacetic Acid binds to and results in increased activity of NR1I2 protein |
CTD |
PMID:21115097 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Nrg1 |
neuregulin 1 |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of NRG1 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr16:59,250,658...60,304,519
Ensembl chr16:59,250,854...60,296,884
|
|
G |
Nt5c1a |
5'-nucleotidase, cytosolic IA |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of NT5C1A mRNA |
CTD |
PMID:37567420 |
|
NCBI chr 5:135,473,107...135,494,400
Ensembl chr 5:135,473,231...135,499,338
|
|
G |
Ntm |
neurotrimin |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of NTM mRNA |
CTD |
PMID:37567420 |
|
NCBI chr 8:27,376,582...28,366,604
Ensembl chr 8:27,377,773...28,366,595
|
|
G |
Nxph4 |
neurexophilin 4 |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of NXPH4 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr 7:63,367,758...63,376,579
Ensembl chr 7:63,367,761...63,376,579
|
|
G |
Ocln |
occludin |
decreases expression |
EXP |
2,4-Dichlorophenoxyacetic Acid results in decreased expression of OCLN mRNA |
CTD |
PMID:28699141 |
|
NCBI chr 2:31,657,217...31,707,466
Ensembl chr 2:31,657,220...31,764,150
|
|
G |
Oxt |
oxytocin/neurophysin I prepropeptide |
decreases secretion |
EXP |
2,4-Dichlorophenoxyacetic Acid results in decreased secretion of OXT protein |
CTD |
PMID:20122984 |
|
NCBI chr 3:117,782,650...117,783,490
Ensembl chr 3:117,782,650...117,783,490
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
multiple interactions |
EXP |
[2,4-dichlorophenoxyacetic acid isooctyl ester results in increased abundance of 2,4-Dichlorophenoxyacetic Acid] promotes the reaction [Ethanol results in increased expression of PARP1 mRNA]; [2,4-dichlorophenoxyacetic acid isooctyl ester results in increased abundance of 2,4-Dichlorophenoxyacetic Acid] which results in increased expression of PARP1 mRNA; Ethanol promotes the reaction [[2,4-dichlorophenoxyacetic acid isooctyl ester results in increased abundance of 2,4-Dichlorophenoxyacetic Acid] which results in increased expression of PARP1 mRNA] |
CTD |
PMID:36085217 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Pcdh10 |
protocadherin 10 |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of PCDH10 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr 2:128,617,212...128,683,354
Ensembl chr 2:128,617,174...128,677,190
|
|
G |
Pcdhga8 |
protocadherin gamma subfamily A, 8 |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of PCDHGA8 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr18:29,553,882...29,667,865
Ensembl chr18:29,493,954...29,667,868
|
|
G |
Pcna |
proliferating cell nuclear antigen |
increases expression decreases expression multiple interactions |
ISO |
2,4-Dichlorophenoxyacetic Acid results in increased expression of PCNA mRNA 2,4-Dichlorophenoxyacetic Acid results in decreased expression of PCNA protein [2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] promotes the reaction [[lard co-treated with Cholesterol co-treated with Glucose co-treated with Sucrose co-treated with Fructose] results in decreased expression of PCNA protein]; [2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] results in decreased expression of PCNA protein; [2,4-Dichlorophenoxyacetic Acid co-treated with lard co-treated with Cholesterol co-treated with Glucose co-treated with Sucrose co-treated with Fructose] results in decreased expression of PCNA protein |
CTD |
PMID:15878651 PMID:37615203 |
|
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Pcsk2 |
proprotein convertase subtilisin/kexin type 2 |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of PCSK2 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr 3:130,880,422...131,183,127
Ensembl chr 3:130,880,422...131,183,127
|
|
G |
Penk |
proenkephalin |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of PENK mRNA |
CTD |
PMID:37567420 |
|
NCBI chr 5:17,183,799...17,189,160
Ensembl chr 5:17,183,806...17,189,129
|
|
G |
Per3 |
period circadian regulator 3 |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of PER3 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr 5:161,460,228...161,495,404
Ensembl chr 5:161,459,533...161,495,607
|
|
G |
Pfkm |
phosphofructokinase, muscle |
decreases expression |
EXP |
2,4-Dichlorophenoxyacetic Acid results in decreased expression of PFKM mRNA; 2,4-Dichlorophenoxyacetic Acid results in decreased expression of PFKM protein |
CTD |
PMID:23538319 |
|
NCBI chr 7:129,221,679...129,259,192
Ensembl chr 7:129,221,653...129,259,192
|
|
G |
Phgdh |
phosphoglycerate dehydrogenase |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of PHGDH mRNA |
CTD |
PMID:37567420 |
|
NCBI chr 2:185,906,962...185,936,054
Ensembl chr 2:185,906,966...185,935,944
|
|
G |
Plxdc1 |
plexin domain containing 1 |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of PLXDC1 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr10:82,922,499...82,982,124
Ensembl chr10:82,922,508...82,982,130
|
|
G |
Pnpla3 |
patatin-like phospholipase domain containing 3 |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of PNPLA3 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr 7:115,293,538...115,314,077
Ensembl chr 7:115,293,538...115,314,077
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
increases response to substance |
ISO |
PPARA protein results in increased susceptibility to 2,4-Dichlorophenoxyacetic Acid |
CTD |
PMID:26838045 |
|
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
|
|
G |
Ppard |
peroxisome proliferator-activated receptor delta |
multiple interactions increases expression |
ISO |
PPARB protein affects the reaction [2,4-Dichlorophenoxyacetic Acid results in increased expression of CREB1 mRNA]; PPARB protein affects the reaction [2,4-Dichlorophenoxyacetic Acid results in increased expression of FOXO1 mRNA] 2,4-Dichlorophenoxyacetic Acid results in increased expression of PPARB mRNA |
CTD |
PMID:29633193 |
|
NCBI chr20:6,298,785...6,363,970
Ensembl chr20:6,298,785...6,363,968
|
|
G |
Prl |
prolactin |
decreases secretion |
EXP |
2,4-Dichlorophenoxyacetic Acid results in decreased secretion of PRL protein |
CTD |
PMID:20122984 |
|
NCBI chr17:37,859,999...37,870,062
Ensembl chr17:37,860,007...37,870,062
|
|
G |
Prok1 |
prokineticin 1 |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of PROK1 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr 2:194,850,539...194,859,343
Ensembl chr 2:194,853,991...194,859,250
|
|
G |
Prr33 |
proline rich 33 |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of PRR33 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr 1:197,644,903...197,650,774
Ensembl chr 1:197,644,902...197,650,714
|
|
G |
Ptger3 |
prostaglandin E receptor 3 |
decreases expression |
ISO |
2,4-Dichlorophenoxyacetic Acid results in decreased expression of PTGER3 mRNA |
CTD |
PMID:15878651 |
|
NCBI chr 2:246,606,131...246,750,970
Ensembl chr 2:246,606,183...246,684,434
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
EXP |
[2,4-dichlorophenoxyacetic acid isooctyl ester results in increased abundance of 2,4-Dichlorophenoxyacetic Acid] promotes the reaction [Ethanol results in increased expression of PTGS2 mRNA]; [2,4-dichlorophenoxyacetic acid isooctyl ester results in increased abundance of 2,4-Dichlorophenoxyacetic Acid] which results in increased expression of PTGS2 mRNA; Ethanol promotes the reaction [[2,4-dichlorophenoxyacetic acid isooctyl ester results in increased abundance of 2,4-Dichlorophenoxyacetic Acid] which results in increased expression of PTGS2 mRNA] |
CTD |
PMID:36085217 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Pycard |
PYD and CARD domain containing |
increases expression multiple interactions |
EXP |
2,4-Dichlorophenoxyacetic Acid results in increased expression of PYCARD protein lycium barbarum polysaccharide inhibits the reaction [2,4-Dichlorophenoxyacetic Acid results in increased expression of PYCARD protein] |
CTD |
PMID:34464015 |
|
NCBI chr 1:182,601,657...182,603,013
Ensembl chr 1:182,601,174...182,602,955
|
|
G |
R3hdml |
R3H domain containing-like |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of R3HDML mRNA |
CTD |
PMID:37567420 |
|
NCBI chr 3:152,171,382...152,182,151
Ensembl chr 3:152,171,382...152,182,151
|
|
G |
Rasl12 |
RAS-like, family 12 |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of RASL12 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr 8:65,917,840...65,931,885
Ensembl chr 8:65,917,840...65,932,741
|
|
G |
Rbpjl |
recombination signal binding protein for immunoglobulin kappa J region-like |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of RBPJL mRNA |
CTD |
PMID:37567420 |
|
NCBI chr 3:153,134,044...153,147,421
Ensembl chr 3:153,134,140...153,146,513
|
|
G |
Rd3 |
RD3 regulator of GUCY2D |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of RD3 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr13:103,551,823...103,562,925
Ensembl chr13:103,552,857...103,562,622
|
|
G |
Recql4 |
RecQ like helicase 4 |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of RECQL4 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr 7:108,423,453...108,430,790
Ensembl chr 7:108,423,455...108,430,619
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
EXP |
[2,4-dichlorophenoxyacetic acid isooctyl ester results in increased abundance of 2,4-Dichlorophenoxyacetic Acid] promotes the reaction [Ethanol results in increased expression of RELA mRNA]; [2,4-dichlorophenoxyacetic acid isooctyl ester results in increased abundance of 2,4-Dichlorophenoxyacetic Acid] which results in increased expression of RELA mRNA; Ethanol promotes the reaction [[2,4-dichlorophenoxyacetic acid isooctyl ester results in increased abundance of 2,4-Dichlorophenoxyacetic Acid] which results in increased expression of RELA mRNA] |
CTD |
PMID:36085217 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Rmi2 |
RecQ mediated genome instability 2 |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of RMI2 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr10:4,829,333...4,837,264
Ensembl chr10:4,830,553...4,837,235
|
|
G |
Rptn |
repetin |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of RPTN mRNA |
CTD |
PMID:37567420 |
|
NCBI chr 2:179,061,768...179,066,056
Ensembl chr 2:179,060,017...179,065,910
|
|
G |
Sbsn |
suprabasin |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of SBSN mRNA |
CTD |
PMID:37567420 |
|
NCBI chr 1:85,978,970...86,006,034
Ensembl chr 1:86,001,567...86,006,034
|
|
G |
Scarna17 |
small Cajal body-specific RNA 17 |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of SCARNA17 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr18:68,344,475...68,344,553
Ensembl chr18:68,344,475...68,344,553
|
|
G |
Sik1 |
salt-inducible kinase 1 |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of SIK1 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr20:9,949,407...9,959,036
Ensembl chr20:9,947,396...9,958,991
|
|
G |
Slc16a3 |
solute carrier family 16 member 3 |
decreases expression increases expression |
EXP |
2,4-Dichlorophenoxyacetic Acid results in decreased expression of SLC16A3 mRNA 2,4-Dichlorophenoxyacetic Acid results in increased expression of SLC16A3 mRNA |
CTD |
PMID:23538319 |
|
NCBI chr10:106,212,679...106,222,564
Ensembl chr10:106,212,778...106,222,562
|
|
G |
Slc22a12 |
solute carrier family 22 member 12 |
multiple interactions |
ISO |
Potassium promotes the reaction [SLC22A12 protein results in increased uptake of 2,4-Dichlorophenoxyacetic Acid] |
CTD |
PMID:15284287 |
|
NCBI chr 1:203,845,039...203,852,496
Ensembl chr 1:203,845,048...203,853,555
|
|
G |
Slc22a19 |
solute carrier family 22, member 19 |
multiple interactions |
ISO |
2,4-Dichlorophenoxyacetic Acid inhibits the reaction [SLC22A19 protein results in increased uptake of ochratoxin A] |
CTD |
PMID:15068970 |
|
NCBI chr 1:204,910,450...204,965,538
Ensembl chr 1:204,910,455...204,965,538
|
|
G |
Slc22a20 |
solute carrier family 22 member 20 |
multiple interactions |
ISO |
2,4-Dichlorophenoxyacetic Acid inhibits the reaction [SLC22A20 protein results in increased uptake of estrone sulfate] |
CTD |
PMID:16478971 |
|
NCBI chr 1:203,257,374...203,273,854
Ensembl chr 1:203,257,374...203,273,822
|
|
G |
Slc22a3 |
solute carrier family 22 member 3 |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of SLC22A3 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr 1:48,235,476...48,324,617
Ensembl chr 1:48,235,476...48,324,612
|
|
G |
Slc22a6 |
solute carrier family 22 member 6 |
increases uptake multiple interactions |
EXP ISO |
SLC22A6 protein results in increased uptake of 2,4-Dichlorophenoxyacetic Acid p-Aminohippuric Acid inhibits the reaction [SLC22A6 protein results in increased uptake of 2,4-Dichlorophenoxyacetic Acid] |
CTD |
PMID:16857889 PMID:17255469 |
|
NCBI chr 1:205,522,579...205,531,179
Ensembl chr 1:205,522,729...205,531,173
|
|
G |
Slc26a3 |
solute carrier family 26 member 3 |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of SLC26A3 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr 6:48,023,892...48,064,829
Ensembl chr 6:48,023,892...48,064,772
|
|
G |
Slc2a3 |
solute carrier family 2 member 3 |
decreases expression increases expression |
EXP |
2,4-Dichlorophenoxyacetic Acid results in decreased expression of SLC2A3 mRNA; 2,4-Dichlorophenoxyacetic Acid results in decreased expression of SLC2A3 protein 2,4-Dichlorophenoxyacetic Acid results in increased expression of SLC2A3 mRNA |
CTD |
PMID:23538319 |
|
NCBI chr 4:155,960,944...156,026,000
Ensembl chr 4:155,960,946...156,025,472
|
|
G |
Sod1 |
superoxide dismutase 1 |
decreases activity multiple interactions |
ISO |
2,4-Dichlorophenoxyacetic Acid results in decreased activity of SOD1 protein 2,4-Dichlorophenoxyacetic Acid inhibits the reaction [[Sucrose co-treated with Dietary Fats] results in increased expression of SOD1 mRNA] |
CTD |
PMID:35099110 PMID:37516258 |
|
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Spp1 |
secreted phosphoprotein 1 |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of SPP1 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
|
|
G |
Spta1 |
spectrin, alpha, erythrocytic 1 |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of SPTA1 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr13:86,203,504...86,279,371
Ensembl chr13:86,203,504...86,279,371
|
|
G |
Sqstm1 |
sequestosome 1 |
multiple interactions increases expression |
EXP ISO |
lycium barbarum polysaccharide inhibits the reaction [2,4-Dichlorophenoxyacetic Acid results in increased expression of SQSTM1 mRNA]; lycium barbarum polysaccharide inhibits the reaction [2,4-Dichlorophenoxyacetic Acid results in increased expression of SQSTM1 protein] 2,4-Dichlorophenoxyacetic Acid results in increased expression of SQSTM1 mRNA; 2,4-Dichlorophenoxyacetic Acid results in increased expression of SQSTM1 protein lycium barbarum polysaccharide inhibits the reaction [2,4-Dichlorophenoxyacetic Acid results in increased expression of SQSTM1 mRNA]; lycium barbarum polysaccharide inhibits the reaction [2,4-Dichlorophenoxyacetic Acid results in increased expression of SQSTM1 protein]; NLRP3 protein promotes the reaction [2,4-Dichlorophenoxyacetic Acid results in increased expression of SQSTM1 mRNA]; NLRP3 protein promotes the reaction [2,4-Dichlorophenoxyacetic Acid results in increased expression of SQSTM1 protein] |
CTD |
PMID:34464015 PMID:35099110 |
|
NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673
|
|
G |
Srxn1 |
sulfiredoxin 1 |
increases expression |
ISO |
2,4-Dichlorophenoxyacetic Acid results in increased expression of SRXN1 mRNA |
CTD |
PMID:34626751 |
|
NCBI chr 3:140,604,490...140,610,050
Ensembl chr 3:140,599,608...140,628,448
|
|
G |
Stx19 |
syntaxin 19 |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of STX19 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr11:172,855...178,053
Ensembl chr11:171,395...179,191
|
|
G |
Tbx15 |
T-box transcription factor 15 |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of TBX15 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr 2:186,576,650...186,687,748
Ensembl chr 2:186,576,676...186,687,663
|
|
G |
Tdrd9 |
tudor domain containing 9 |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of TDRD9 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr 6:131,029,644...131,145,076
Ensembl chr 6:131,029,652...131,144,651
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
multiple interactions |
EXP |
[2,4-dichlorophenoxyacetic acid isooctyl ester results in increased abundance of 2,4-Dichlorophenoxyacetic Acid] affects the reaction [Ethanol results in increased expression of TGFB1 mRNA]; [2,4-dichlorophenoxyacetic acid isooctyl ester results in increased abundance of 2,4-Dichlorophenoxyacetic Acid] which results in increased expression of TGFB1 mRNA; Ethanol affects the reaction [[2,4-dichlorophenoxyacetic acid isooctyl ester results in increased abundance of 2,4-Dichlorophenoxyacetic Acid] which results in increased expression of TGFB1 mRNA] |
CTD |
PMID:36085217 |
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Th |
tyrosine hydroxylase |
increases expression |
EXP |
2,4-Dichlorophenoxyacetic Acid results in increased expression of TH protein |
CTD |
PMID:16931444 |
|
NCBI chr 1:198,071,500...198,078,832
Ensembl chr 1:198,071,503...198,109,767
|
|
G |
Thrb |
thyroid hormone receptor beta |
affects binding |
ISO |
2,4-Dichlorophenoxyacetic Acid binds to THRB protein |
CTD |
PMID:27410513 |
|
NCBI chr15:7,685,180...8,031,920
Ensembl chr15:7,685,180...7,882,916
|
|
G |
Tjp1 |
tight junction protein 1 |
decreases expression |
EXP |
2,4-Dichlorophenoxyacetic Acid results in decreased expression of TJP1 mRNA; 2,4-Dichlorophenoxyacetic Acid results in decreased expression of TJP1 protein |
CTD |
PMID:28699141 |
|
NCBI chr 1:118,849,838...119,094,492
Ensembl chr 1:118,849,838...119,094,432
|
|
G |
Tlcd2 |
TLC domain containing 2 |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of TLCD2 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr10:60,310,577...60,314,263
Ensembl chr10:60,311,099...60,313,622
|
|
G |
Tmem232 |
transmembrane protein 232 |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of TMEM232 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr 9:104,887,669...105,115,737
Ensembl chr 9:104,887,669...105,143,027
|
|
G |
Tmem52 |
transmembrane protein 52 |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of TMEM52 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr 5:166,048,669...166,050,423
Ensembl chr 5:166,046,565...166,050,433
|
|
G |
Tnf |
tumor necrosis factor |
increases expression multiple interactions |
ISO EXP |
2,4-Dichlorophenoxyacetic Acid results in increased expression of TNF; 2,4-Dichlorophenoxyacetic Acid results in increased expression of TNF protein 2,4-Dichlorophenoxyacetic Acid inhibits the reaction [[Sucrose co-treated with Dietary Fats] results in increased expression of TNF mRNA]; lycium barbarum polysaccharide inhibits the reaction [2,4-Dichlorophenoxyacetic Acid results in increased expression of TNF protein] [2,4-dichlorophenoxyacetic acid isooctyl ester results in increased abundance of 2,4-Dichlorophenoxyacetic Acid] promotes the reaction [Ethanol results in increased expression of TNF mRNA]; [2,4-dichlorophenoxyacetic acid isooctyl ester results in increased abundance of 2,4-Dichlorophenoxyacetic Acid] which results in increased expression of TNF mRNA; Ethanol promotes the reaction [[2,4-dichlorophenoxyacetic acid isooctyl ester results in increased abundance of 2,4-Dichlorophenoxyacetic Acid] which results in increased expression of TNF mRNA]; lycium barbarum polysaccharide inhibits the reaction [2,4-Dichlorophenoxyacetic Acid results in increased expression of TNF protein] |
CTD |
PMID:20728597 PMID:34464015 PMID:35099110 PMID:36085217 PMID:37516258 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfsf14 |
TNF superfamily member 14 |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of TNFSF14 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr 9:2,068,295...2,073,128
Ensembl chr 9:2,069,104...2,073,216
|
|
G |
Tp53 |
tumor protein p53 |
multiple interactions increases expression |
ISO EXP |
2,4-Dichlorophenoxyacetic Acid inhibits the reaction [[Sucrose co-treated with Dietary Fats] results in increased expression of TP53 mRNA]; [Lipopolysaccharides co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of TRP53 mRNA; [Lipopolysaccharides co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of TRP53 protein [2,4-dichlorophenoxyacetic acid isooctyl ester results in increased abundance of 2,4-Dichlorophenoxyacetic Acid] promotes the reaction [Ethanol results in increased expression of TP53 mRNA]; [2,4-dichlorophenoxyacetic acid isooctyl ester results in increased abundance of 2,4-Dichlorophenoxyacetic Acid] which results in increased expression of TP53 mRNA; Ethanol promotes the reaction [[2,4-dichlorophenoxyacetic acid isooctyl ester results in increased abundance of 2,4-Dichlorophenoxyacetic Acid] which results in increased expression of TP53 mRNA] 2,4-Dichlorophenoxyacetic Acid results in increased expression of TRP53 mRNA; 2,4-Dichlorophenoxyacetic Acid results in increased expression of TRP53 protein |
CTD |
PMID:33865415 PMID:36085217 PMID:37516258 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Tp73 |
tumor protein p73 |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of TRP73 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr 5:164,621,377...164,703,958
Ensembl chr 5:164,621,377...164,681,128
|
|
G |
Tpsb2 |
tryptase beta 2 |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of TPSB2 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr10:14,381,779...14,383,571
Ensembl chr10:14,382,013...14,383,569
|
|
G |
Tsku |
tsukushi, small leucine rich proteoglycan |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of TSKU mRNA |
CTD |
PMID:37567420 |
|
NCBI chr 1:152,660,259...152,671,682
Ensembl chr 1:152,656,693...152,672,588
|
|
G |
Ugt1a1 |
UDP glucuronosyltransferase family 1 member A1 |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of UGT1A1 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr 9:88,801,344...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt1a2 |
UDP glucuronosyltransferase 1 family, polypeptide A2 |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of UGT1A2 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr 9:88,791,216...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Upp2 |
uridine phosphorylase 2 |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of UPP2 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr 3:43,273,048...43,317,417
Ensembl chr 3:43,273,048...43,317,417
|
|
G |
Usp19 |
ubiquitin specific peptidase 19 |
increases expression |
ISO |
2,4-Dichlorophenoxyacetic Acid results in increased expression of USP19 mRNA |
CTD |
PMID:15878651 |
|
NCBI chr 8:109,190,727...109,201,761
Ensembl chr 8:109,190,724...109,201,741
|
|
G |
Vash2 |
vasohibin 2 |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of VASH2 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr13:102,529,718...102,561,204
Ensembl chr13:102,529,719...102,560,391
|
|
G |
Vegfa |
vascular endothelial growth factor A |
decreases expression |
ISO |
2,4-Dichlorophenoxyacetic Acid results in decreased expression of VEGFA mRNA |
CTD |
PMID:15878651 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
G |
Vwa1 |
von Willebrand factor A domain containing 1 |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of VWA1 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr 5:166,377,451...166,382,784
Ensembl chr 5:166,377,455...166,382,637
|
|
G |
Zfand4 |
zinc finger AN1-type containing 4 |
multiple interactions |
ISO |
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of ZFAND4 mRNA |
CTD |
PMID:37567420 |
|
NCBI chr 4:149,327,339...149,399,495
Ensembl chr 4:149,327,412...149,399,487
|
|
|
G |
A4galt |
alpha 1,4-galactosyltransferase |
increases expression |
ISO |
Diquat results in increased expression of A4GALT mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 7:114,368,525...114,392,872
Ensembl chr 7:114,368,276...114,396,071
|
|
G |
Abcb1b |
ATP-binding cassette, sub-family B member 1B |
increases expression |
ISO |
Diquat results in increased expression of ABCB1B mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 4:25,242,761...25,325,194
Ensembl chr 4:25,242,798...25,325,199
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
increases expression |
ISO |
Diquat results in increased expression of ABCC2 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
|
|
G |
Abcc4 |
ATP binding cassette subfamily C member 4 |
increases expression |
ISO |
Diquat results in increased expression of ABCC4 mRNA; Diquat results in increased expression of ABCC4 protein |
CTD |
PMID:36851058 |
|
NCBI chr15:95,541,186...95,774,898
Ensembl chr15:95,542,315...95,774,283
|
|
G |
Abhd14a |
abhydrolase domain containing 14A |
decreases expression |
ISO |
Diquat results in decreased expression of ABHD14A mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 8:107,079,139...107,089,004
Ensembl chr 8:107,079,144...107,086,985
|
|
G |
Abhd15 |
abhydrolase domain containing 15 |
increases expression |
ISO |
Diquat results in increased expression of ABHD15 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr10:62,363,209...62,368,600
Ensembl chr10:62,363,209...62,368,600
|
|
G |
Abhd4 |
abhydrolase domain containing 4, N-acyl phospholipase B |
increases expression |
ISO |
Diquat results in increased expression of ABHD4 protein |
CTD |
PMID:36851058 |
|
NCBI chr15:27,697,384...27,716,013
Ensembl chr15:27,704,113...27,716,966
|
|
G |
Abi3bp |
ABI family member 3 binding protein |
decreases expression |
ISO |
Diquat results in decreased expression of ABI3BP mRNA |
CTD |
PMID:36851058 |
|
NCBI chr11:43,912,187...44,128,888
Ensembl chr11:43,913,043...44,128,929
|
|
G |
Acaa1b |
acetyl-Coenzyme A acyltransferase 1B |
increases expression |
ISO |
Diquat results in increased expression of ACAA1B mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 8:118,872,996...118,881,852
Ensembl chr 8:118,872,997...118,881,825
|
|
G |
Acaa2 |
acetyl-CoA acyltransferase 2 |
increases expression |
ISO |
Diquat results in increased expression of ACAA2 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr18:68,345,136...68,373,246
Ensembl chr18:68,345,012...68,373,249
|
|
G |
Acot1 |
acyl-CoA thioesterase 1 |
increases expression |
ISO |
Diquat results in increased expression of ACOT1 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 6:103,636,173...103,644,167
Ensembl chr 6:103,636,041...103,644,163
|
|
G |
Acot2 |
acyl-CoA thioesterase 2 |
increases expression |
ISO |
Diquat results in increased expression of ACOT2 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 6:103,611,738...103,619,404
Ensembl chr 6:103,611,544...103,619,245
|
|
G |
Acot3 |
acyl-CoA thioesterase 3 |
increases expression |
ISO |
Diquat results in increased expression of ACOT3 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 6:103,682,518...103,688,735
Ensembl chr 6:103,682,596...103,688,427 Ensembl chr 6:103,682,596...103,688,427
|
|
G |
Acot8 |
acyl-CoA thioesterase 8 |
increases expression |
ISO |
Diquat results in increased expression of ACOT8 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 3:153,531,192...153,542,851
Ensembl chr 3:153,531,193...153,542,851
|
|
G |
Acox1 |
acyl-CoA oxidase 1 |
increases expression |
ISO |
Diquat results in increased expression of ACOX1 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr10:101,406,197...101,431,252
Ensembl chr10:101,406,197...101,431,232
|
|
G |
Acox2 |
acyl-CoA oxidase 2 |
increases expression |
ISO |
Diquat results in increased expression of ACOX2 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr15:16,660,584...16,692,160
Ensembl chr15:16,660,272...16,692,160
|
|
G |
Acp3 |
acid phosphatase 3 |
decreases expression |
ISO |
Diquat results in decreased expression of ACP3 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 8:104,905,570...104,956,146
Ensembl chr 8:104,905,586...104,954,236
|
|
G |
Acsf2 |
acyl-CoA synthetase family member 2 |
increases expression |
ISO |
Diquat results in increased expression of ACSF2 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr10:79,504,510...79,546,714
Ensembl chr10:79,504,511...79,546,673
|
|
G |
Acsl1 |
acyl-CoA synthetase long-chain family member 1 |
increases expression decreases expression |
ISO |
Diquat results in increased expression of ACSL1 mRNA Diquat results in decreased expression of ACSL1 protein |
CTD |
PMID:36851058 PMID:38128689 |
|
NCBI chr16:45,755,246...45,821,541
Ensembl chr16:45,755,254...45,821,541
|
|
G |
Acsl3 |
acyl-CoA synthetase long-chain family member 3 |
decreases expression |
ISO |
Diquat results in decreased expression of ACSL3 protein |
CTD |
PMID:36851058 |
|
NCBI chr 9:80,115,164...80,164,636
Ensembl chr 9:80,115,112...80,164,627
|
|
G |
Acsl4 |
acyl-CoA synthetase long-chain family member 4 |
decreases expression |
ISO |
Diquat results in decreased expression of ACSL4 protein |
CTD |
PMID:38128689 |
|
NCBI chr X:105,942,794...106,006,573
Ensembl chr X:105,942,799...106,006,427
|
|
G |
Actbl2 |
actin, beta-like 2 |
decreases expression |
ISO |
Diquat results in decreased expression of ACTBL2 protein |
CTD |
PMID:36851058 |
|
NCBI chr 2:42,858,020...42,860,767
Ensembl chr 2:42,858,020...42,860,767
|
|
G |
Adam12 |
ADAM metallopeptidase domain 12 |
decreases expression |
ISO |
Diquat results in decreased expression of ADAM12 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 1:188,686,984...189,014,206
Ensembl chr 1:188,686,989...189,020,667
|
|
G |
Adam19 |
ADAM metallopeptidase domain 19 |
decreases expression |
ISO |
Diquat results in decreased expression of ADAM19 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr10:30,491,362...30,583,115
Ensembl chr10:30,491,405...30,583,105
|
|
G |
Adam22 |
ADAM metallopeptidase domain 22 |
increases expression |
ISO |
Diquat results in increased expression of ADAM22 protein |
CTD |
PMID:36851058 |
|
NCBI chr 4:25,716,055...25,970,932
Ensembl chr 4:25,715,990...25,964,962
|
|
G |
Adamts2 |
ADAM metallopeptidase with thrombospondin type 1 motif, 2 |
decreases expression |
ISO |
Diquat results in decreased expression of ADAMTS2 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr10:34,920,992...35,126,465
Ensembl chr10:34,921,049...35,123,821
|
|
G |
Adamts5 |
ADAM metallopeptidase with thrombospondin type 1 motif, 5 |
decreases expression |
ISO |
Diquat results in decreased expression of ADAMTS5 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr11:25,000,627...25,047,205
Ensembl chr11:25,000,637...25,047,205
|
|
G |
Adgrg1 |
adhesion G protein-coupled receptor G1 |
increases expression |
ISO |
Diquat results in increased expression of ADGRG1 protein |
CTD |
PMID:36851058 |
|
NCBI chr19:10,003,963...10,041,122
Ensembl chr19:10,003,975...10,041,108
|
|
G |
Adgrg4 |
adhesion G protein-coupled receptor G4 |
decreases expression |
ISO |
Diquat results in decreased expression of ADGRG4 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr X:134,734,610...134,864,449
Ensembl chr X:134,854,736...134,864,449
|
|
G |
Adgrl4 |
adhesion G protein-coupled receptor L4 |
decreases expression |
ISO |
Diquat results in decreased expression of ADGRL4 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 2:240,354,909...240,457,231
Ensembl chr 2:240,354,941...240,457,225
|
|
G |
Adh7 |
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide |
decreases expression |
ISO |
Diquat results in decreased expression of ADH7 protein |
CTD |
PMID:36851058 |
|
NCBI chr 2:226,748,724...226,763,183
Ensembl chr 2:226,741,788...226,763,182
|
|
G |
Adm |
adrenomedullin |
increases expression |
ISO |
Diquat results in increased expression of ADM mRNA |
CTD |
PMID:21172416 PMID:36851058 |
|
NCBI chr 1:164,745,484...164,747,655
Ensembl chr 1:164,745,466...164,747,654
|
|
G |
Adora2b |
adenosine A2B receptor |
increases expression |
ISO |
Diquat results in increased expression of ADORA2B mRNA |
CTD |
PMID:21172416 PMID:36851058 |
|
NCBI chr10:46,940,394...46,956,772
Ensembl chr10:46,940,384...46,956,772
|
|
G |
Adra1d |
adrenoceptor alpha 1D |
increases expression |
ISO |
Diquat results in increased expression of ADRA1D mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 3:118,793,356...118,809,354
Ensembl chr 3:118,793,346...118,809,354
|
|
G |
Adra2b |
adrenoceptor alpha 2B |
increases expression |
ISO |
Diquat results in increased expression of ADRA2B mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 3:114,585,174...114,589,220
Ensembl chr 3:114,585,169...114,589,355
|
|
G |
Agps |
alkylglycerone phosphate synthase |
decreases expression |
ISO |
Diquat results in decreased expression of AGPS mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 3:60,747,323...60,845,831
Ensembl chr 3:60,747,323...60,845,830
|
|
G |
Agt |
angiotensinogen |
increases expression |
ISO |
Diquat results in increased expression of AGT mRNA |
CTD |
PMID:36851058 |
|
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
|
|
G |
Ahsg |
alpha-2-HS-glycoprotein |
increases expression |
ISO |
Diquat results in increased expression of AHSG protein |
CTD |
PMID:36851058 |
|
NCBI chr11:78,121,388...78,127,998
Ensembl chr11:78,117,918...78,145,999
|
|
G |
Ak5 |
adenylate kinase 5 |
decreases expression |
ISO |
Diquat results in decreased expression of AK5 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 2:241,397,297...241,581,483
Ensembl chr 2:241,397,297...241,581,458
|
|
G |
Akr1b1 |
aldo-keto reductase family 1 member B1 |
decreases expression |
ISO |
Diquat results in decreased expression of AKR1B1 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 4:62,932,033...62,946,126
Ensembl chr 4:62,932,031...62,946,157
|
|
G |
Akr1b10 |
aldo-keto reductase family 1 member B10 |
increases expression |
ISO |
Diquat results in increased expression of AKR1B10 mRNA |
CTD |
PMID:21172416 |
|
NCBI chr 4:63,038,459...63,060,336
Ensembl chr 4:63,040,169...63,053,852
|
|
G |
Akr1c1 |
aldo-keto reductase family 1, member C1 |
increases expression |
ISO |
Diquat results in increased expression of AKR1C1 mRNA |
CTD |
PMID:21172416 |
|
NCBI chr17:65,810,474...65,837,385
Ensembl chr17:65,810,475...65,837,326
|
|
G |
Akr1c2 |
aldo-keto reductase family 1, member C2 |
increases expression |
ISO |
Diquat results in increased expression of AKR1C2 mRNA |
CTD |
PMID:21172416 |
|
NCBI chr17:65,759,778...65,808,013
Ensembl chr17:65,759,788...65,775,764
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions increases phosphorylation |
ISO |
PROP1 protein affects the reaction [Diquat results in increased phosphorylation of AKT1 protein] |
CTD |
PMID:20826540 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Alas1 |
5'-aminolevulinate synthase 1 |
increases expression |
ISO |
Diquat results in increased expression of ALAS1 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 8:106,876,514...106,889,917
Ensembl chr 8:106,876,514...106,889,917
|
|
G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
increases expression |
ISO |
Diquat results in increased expression of ALDH1A1 mRNA; Diquat results in increased expression of ALDH1A1 protein |
CTD |
PMID:36851058 |
|
NCBI chr 1:218,000,470...218,152,962
Ensembl chr 1:218,042,127...218,152,961
|
|
G |
Aldh1a2 |
aldehyde dehydrogenase 1 family, member A2 |
decreases expression |
ISO |
Diquat results in decreased expression of ALDH1A2 protein |
CTD |
PMID:36851058 |
|
NCBI chr 8:71,877,850...71,957,107
Ensembl chr 8:71,877,850...71,957,107
|
|
G |
Aldh1a3 |
aldehyde dehydrogenase 1 family, member A3 |
decreases expression |
ISO |
Diquat results in decreased expression of ALDH1A3 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 1:119,982,272...120,017,416
Ensembl chr 1:119,982,277...120,017,436
|
|
G |
Aldh1l1 |
aldehyde dehydrogenase 1 family, member L1 |
increases expression |
ISO |
Diquat results in increased expression of ALDH1L1 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 4:123,059,989...123,106,471
Ensembl chr 4:123,060,008...123,106,465
|
|
G |
Aldh3b1 |
aldehyde dehydrogenase 3 family, member B1 |
increases expression |
ISO |
Diquat results in increased expression of ALDH3B1 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 1:201,145,309...201,162,675
Ensembl chr 1:201,145,309...201,163,921
|
|
G |
Alox15 |
arachidonate 15-lipoxygenase |
increases expression |
ISO |
Diquat results in increased expression of ALOX15 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr10:55,060,169...55,068,885
Ensembl chr10:55,060,412...55,068,874
|
|
G |
Alpl |
alkaline phosphatase, biomineralization associated |
increases expression |
ISO |
Diquat results in increased expression of ALPL mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 5:149,951,397...150,006,424
Ensembl chr 5:149,951,409...150,006,446
|
|
G |
Alx1 |
ALX homeobox 1 |
decreases expression |
ISO |
Diquat results in decreased expression of ALX1 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 7:38,157,626...38,177,220
Ensembl chr 7:38,147,117...38,177,220
|
|
G |
Amacr |
alpha-methylacyl-CoA racemase |
decreases expression |
ISO |
Diquat results in decreased expression of AMACR mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 2:59,946,158...59,958,255
Ensembl chr 2:59,946,153...59,958,255
|
|
G |
Angpt2 |
angiopoietin 2 |
decreases expression |
ISO |
Diquat results in decreased expression of ANGPT2 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr16:71,088,364...71,138,805
Ensembl chr16:71,088,364...71,138,804
|
|
G |
Angptl4 |
angiopoietin-like 4 |
increases expression |
ISO |
Diquat results in increased expression of ANGPTL4 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 7:14,550,288...14,557,797
Ensembl chr 7:14,550,311...14,556,519
|
|
G |
Angptl7 |
angiopoietin like 7 |
decreases expression |
ISO |
Diquat results in decreased expression of ANGPTL7 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 5:158,932,096...158,937,281
Ensembl chr 5:158,932,794...158,937,324
|
|
G |
Angptl8 |
angiopoietin-like 8 |
increases expression |
ISO |
Diquat results in increased expression of ANGPTL8 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 8:20,376,462...20,378,488
Ensembl chr 8:20,376,462...20,378,490
|
|
G |
Ankrd1 |
ankyrin repeat domain 1 |
increases expression |
ISO |
Diquat results in increased expression of ANKRD1 mRNA |
CTD |
PMID:21172416 |
|
NCBI chr 1:233,815,851...233,834,891
Ensembl chr 1:233,815,851...233,834,919
|
|
G |
Ankrd13a |
ankyrin repeat domain 13a |
decreases expression |
ISO |
Diquat results in decreased expression of ANKRD13A protein |
CTD |
PMID:36851058 |
|
NCBI chr12:41,798,196...41,828,327
Ensembl chr12:41,798,199...41,829,327
|
|
G |
Ankrd34b |
ankyrin repeat domain 34B |
decreases expression |
ISO |
Diquat results in decreased expression of ANKRD34B mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 2:23,651,083...23,668,041
Ensembl chr 2:23,651,474...23,668,030
|
|
G |
Anks1b |
ankyrin repeat and sterile alpha motif domain containing 1B |
decreases expression |
ISO |
Diquat results in decreased expression of ANKS1B mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 7:24,313,339...25,479,307
Ensembl chr 7:24,312,843...25,477,693
|
|
G |
Ano4 |
anoctamin 4 |
decreases expression |
ISO |
Diquat results in decreased expression of ANO4 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 7:23,329,015...23,738,423
Ensembl chr 7:23,329,070...23,738,434
|
|
G |
Ano5 |
anoctamin 5 |
decreases expression |
ISO |
Diquat results in decreased expression of ANO5 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 1:101,086,490...101,187,547
Ensembl chr 1:101,087,341...101,187,555
|
|
G |
Aox1 |
aldehyde oxidase 1 |
increases expression |
ISO |
Diquat results in increased expression of AOX1 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 9:59,579,621...59,658,772
Ensembl chr 9:59,579,649...59,658,770
|
|
G |
Apbb1ip |
amyloid beta precursor protein binding family B member 1 interacting protein |
decreases expression |
ISO |
Diquat results in decreased expression of APBB1IP mRNA |
CTD |
PMID:36851058 |
|
NCBI chr17:84,941,404...85,033,020
Ensembl chr17:84,982,243...85,033,010
|
|
G |
Apbb2 |
amyloid beta precursor protein binding family B member 2 |
decreases expression |
ISO |
Diquat results in decreased expression of APBB2 protein |
CTD |
PMID:36851058 |
|
NCBI chr14:41,557,918...41,878,622
Ensembl chr14:41,557,972...41,877,495
|
|
G |
Apcs |
amyloid P component, serum |
decreases expression |
ISO |
Diquat results in decreased expression of APCS mRNA |
CTD |
PMID:36851058 |
|
NCBI chr13:85,373,219...85,374,195
Ensembl chr13:85,373,220...85,374,298
|
|
G |
Aplnr |
apelin receptor |
decreases expression |
ISO |
Diquat results in decreased expression of APLNR mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 3:70,217,407...70,221,052
Ensembl chr 3:70,217,385...70,221,050
|
|
G |
Apoa2 |
apolipoprotein A2 |
increases expression |
ISO |
Diquat results in increased expression of APOA2 protein |
CTD |
PMID:36851058 |
|
NCBI chr13:83,644,460...83,646,358
Ensembl chr13:83,644,470...83,646,355
|
|
G |
Apoa4 |
apolipoprotein A4 |
increases expression |
ISO |
Diquat results in increased expression of APOA4 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 8:46,539,083...46,541,464
Ensembl chr 8:46,539,082...46,541,469
|
|
G |
Apoc3 |
apolipoprotein C3 |
increases expression decreases expression |
ISO |
Diquat results in increased expression of APOC3 mRNA Diquat results in decreased expression of APOC3 protein |
CTD |
PMID:36851058 |
|
NCBI chr 8:46,531,478...46,533,658
Ensembl chr 8:46,531,478...46,533,583
|
|
G |
Apod |
apolipoprotein D |
increases expression |
ISO |
Diquat results in increased expression of APOD mRNA |
CTD |
PMID:36851058 |
|
NCBI chr11:69,431,261...69,452,306
Ensembl chr11:69,431,260...69,452,305
|
|
G |
Apoe |
apolipoprotein E |
increases expression |
ISO |
Diquat results in increased expression of APOE mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932
|
|
G |
Apoh |
apolipoprotein H |
increases expression |
ISO |
Diquat results in increased expression of APOH mRNA |
CTD |
PMID:36851058 |
|
NCBI chr10:93,342,435...93,356,334
Ensembl chr10:93,310,977...93,356,329
|
|
G |
Apom |
apolipoprotein M |
decreases expression |
ISO |
Diquat results in decreased expression of APOM protein |
CTD |
PMID:36851058 |
|
NCBI chr20:3,690,950...3,693,550
Ensembl chr20:3,688,413...3,693,550
|
|
G |
Aqp1 |
aquaporin 1 |
increases expression |
ISO |
Diquat results in increased expression of AQP1 protein |
CTD |
PMID:36851058 |
|
NCBI chr 4:84,482,512...84,494,690
Ensembl chr 4:84,482,512...84,494,690
|
|
G |
Aqp3 |
aquaporin 3 (Gill blood group) |
increases expression |
ISO |
Diquat results in increased expression of AQP3 protein |
CTD |
PMID:36851058 |
|
NCBI chr 5:56,239,200...56,244,718
Ensembl chr 5:56,239,201...56,244,720
|
|
G |
Aqp4 |
aquaporin 4 |
decreases expression |
ISO |
Diquat results in decreased expression of AQP4 protein |
CTD |
PMID:36851058 |
|
NCBI chr18:6,507,903...6,524,558
Ensembl chr18:6,507,903...6,524,856
|
|
G |
Aqp8 |
aquaporin 8 |
increases expression |
ISO |
Diquat results in increased expression of AQP8 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 1:177,993,313...177,999,158
Ensembl chr 1:177,993,305...177,999,158
|
|
G |
Areg |
amphiregulin |
increases expression |
ISO |
Diquat results in increased expression of AREG mRNA |
CTD |
PMID:36851058 |
|
NCBI chr14:16,972,185...16,981,443
Ensembl chr14:16,972,187...16,981,535
|
|
G |
Arg2 |
arginase 2 |
increases expression |
ISO |
Diquat results in increased expression of ARG2 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 6:97,936,002...97,961,379
Ensembl chr 6:97,936,002...97,961,378
|
|
G |
Arhgap30 |
Rho GTPase activating protein 30 |
decreases expression |
ISO |
Diquat results in decreased expression of ARHGAP30 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr13:83,822,290...83,843,634
Ensembl chr13:83,822,283...83,854,885
|
|
G |
Arhgap35 |
Rho GTPase activating protein 35 |
decreases expression |
ISO |
Diquat results in decreased expression of ARHGAP35 protein |
CTD |
PMID:36851058 |
|
NCBI chr 1:77,202,436...77,319,298
Ensembl chr 1:77,202,436...77,319,298
|
|
G |
Arhgef6 |
Rac/Cdc42 guanine nucleotide exchange factor 6 |
decreases expression |
ISO |
Diquat results in decreased expression of ARHGEF6 protein |
CTD |
PMID:36851058 |
|
NCBI chr X:135,145,447...135,264,636
Ensembl chr X:135,146,786...135,275,304
|
|
G |
Armc12 |
armadillo repeat containing 12 |
increases expression |
ISO |
Diquat results in increased expression of ARMC12 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr20:6,587,859...6,598,355
Ensembl chr20:6,587,859...6,598,352
|
|
G |
Armh4 |
armadillo-like helical domain containing 4 |
decreases expression |
ISO |
Diquat results in decreased expression of ARMH4 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr15:22,975,895...23,076,986
Ensembl chr15:22,975,895...23,076,949
|
|
G |
Art4 |
ADP-ribosyltransferase 4 |
decreases expression |
ISO |
Diquat results in decreased expression of ART4 protein |
CTD |
PMID:36851058 |
|
NCBI chr 4:169,740,331...169,751,571
Ensembl chr 4:169,740,331...169,750,665
|
|
G |
Asb11 |
ankyrin repeat and SOCS box containing 11 |
increases expression |
ISO |
Diquat results in increased expression of ASB11 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr X:30,014,485...30,037,808
Ensembl chr X:29,992,416...30,037,807
|
|
G |
Asb9 |
ankyrin repeat and SOCS box-containing 9 |
increases expression |
ISO |
Diquat results in increased expression of ASB9 protein |
CTD |
PMID:36851058 |
|
NCBI chr X:29,956,576...30,001,436
Ensembl chr X:29,956,576...30,001,105
|
|
G |
Astn1 |
astrotactin 1 |
decreases expression |
ISO |
Diquat results in decreased expression of ASTN1 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr13:70,537,423...70,855,440
Ensembl chr13:70,537,703...70,855,440
|
|
G |
Asxl3 |
ASXL transcriptional regulator 3 |
decreases expression |
ISO |
Diquat results in decreased expression of ASXL3 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr18:13,593,529...13,766,324
Ensembl chr18:13,593,985...13,762,427
|
|
G |
Atf3 |
activating transcription factor 3 |
increases expression |
ISO |
Diquat results in increased expression of ATF3 mRNA |
CTD |
PMID:21172416 PMID:36851058 |
|
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
|
|
G |
Atf5 |
activating transcription factor 5 |
increases expression |
ISO |
Diquat results in increased expression of ATF5 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 1:95,295,602...95,299,755
Ensembl chr 1:95,295,610...95,299,707
|
|
G |
Atf6 |
activating transcription factor 6 |
increases expression |
ISO |
Diquat results in increased expression of ATF6 mRNA |
CTD |
PMID:32536062 |
|
NCBI chr13:82,927,579...83,106,381
Ensembl chr13:82,930,034...83,107,177
|
|
G |
Atg12 |
autophagy related 12 |
multiple interactions |
ISO |
[Diquat co-treated with procyanidin B2] results in increased expression of ATG12 mRNA |
CTD |
PMID:27057282 |
|
NCBI chr18:39,452,247...39,462,424
Ensembl chr18:39,452,191...39,462,418
|
|
G |
Atg5 |
autophagy related 5 |
increases expression |
ISO |
Diquat results in increased expression of ATG5 protein |
CTD |
PMID:38128689 |
|
NCBI chr20:47,798,217...47,889,216
Ensembl chr20:47,798,290...47,889,209
|
|
G |
Atg9b |
autophagy related 9B |
decreases expression |
ISO |
Diquat results in decreased expression of ATG9B mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 4:10,784,934...10,793,832
Ensembl chr 4:10,786,114...10,793,651
|
|
G |
Atox1 |
antioxidant 1 copper chaperone |
decreases expression |
ISO |
Diquat results in decreased expression of ATOX1 protein |
CTD |
PMID:36851058 |
|
NCBI chr10:39,564,855...39,579,892
Ensembl chr10:39,564,857...39,579,950
|
|
G |
Atp11a |
ATPase phospholipid transporting 11A |
decreases expression |
ISO |
Diquat results in decreased expression of ATP11A mRNA |
CTD |
PMID:36851058 |
|
NCBI chr16:76,657,752...76,767,640
Ensembl chr16:76,657,752...76,767,640
|
|
G |
Atp5f1e |
ATP synthase F1 subunit epsilon |
increases expression |
ISO |
Diquat results in increased expression of ATP5F1E protein |
CTD |
PMID:36851058 |
|
NCBI chr 3:163,259,072...163,261,974
Ensembl chr 3:163,260,476...163,261,450
|
|
G |
Atp5mc1 |
ATP synthase membrane subunit c locus 1 |
increases expression |
ISO |
Diquat results in increased expression of ATP5MC1 protein |
CTD |
PMID:36851058 |
|
NCBI chr10:81,024,056...81,026,780
Ensembl chr10:81,023,925...81,027,124 Ensembl chr10:81,023,925...81,027,124
|
|
G |
Atp5pd |
ATP synthase peripheral stalk subunit d |
increases expression |
ISO |
Diquat results in increased expression of ATP5PD protein |
CTD |
PMID:36851058 |
|
NCBI chr10:100,657,700...100,662,960
Ensembl chr10:100,657,708...100,663,479
|
|
G |
Atp6v0a2 |
ATPase H+ transporting V0 subunit a2 |
decreases expression |
ISO |
Diquat results in decreased expression of ATP6V0A2 protein |
CTD |
PMID:36851058 |
|
NCBI chr12:31,947,220...31,979,875
Ensembl chr12:31,822,733...32,007,069
|
|
G |
Atp6v0a4 |
ATPase H+ transporting V0 subunit a4 |
increases expression |
ISO |
Diquat results in increased expression of ATP6V0A4 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 4:66,760,163...66,842,126
Ensembl chr 4:66,760,159...66,842,110
|
|
G |
Atp6v1g3 |
ATPase H+ transporting V1 subunit G3 |
increases expression |
ISO |
Diquat results in increased expression of ATP6V1G3 protein |
CTD |
PMID:36851058 |
|
NCBI chr13:49,800,256...49,825,247
Ensembl chr13:49,794,222...49,825,247
|
|
G |
Atp8b1 |
ATPase phospholipid transporting 8B1 |
decreases expression |
ISO |
Diquat results in decreased expression of ATP8B1 protein |
CTD |
PMID:36851058 |
|
NCBI chr18:58,016,382...58,157,213
Ensembl chr18:58,018,268...58,157,396
|
|
G |
Atrx |
ATRX, chromatin remodeler |
increases expression |
ISO |
Diquat results in increased expression of ATRX protein |
CTD |
PMID:36851058 |
|
NCBI chr X:70,850,981...70,997,330
Ensembl chr X:70,850,981...70,997,330
|
|
G |
B4galt1 |
beta-1,4-galactosyltransferase 1 |
decreases expression |
ISO |
Diquat results in decreased expression of B4GALT1 protein |
CTD |
PMID:36851058 |
|
NCBI chr 5:55,935,614...55,982,461
Ensembl chr 5:55,935,615...55,982,461
|
|
G |
B4galt5 |
beta-1,4-galactosyltransferase 5 |
decreases expression |
ISO |
Diquat results in decreased expression of B4GALT5 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 3:156,018,056...156,033,983
Ensembl chr 3:156,018,053...156,070,074
|
|
G |
Bag2 |
BAG cochaperone 2 |
increases expression |
ISO |
Diquat results in increased expression of BAG2 mRNA; Diquat results in increased expression of BAG2 protein |
CTD |
PMID:36851058 |
|
NCBI chr 9:35,970,033...35,980,677
Ensembl chr 9:35,970,033...35,980,721
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions affects expression increases expression |
ISO |
procyanidin B2 affects the reaction [Diquat affects the expression of BAX mRNA] Diquat results in increased expression of BAX protein |
CTD |
PMID:26785375 PMID:27057282 PMID:38128689 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bbox1 |
gamma-butyrobetaine hydroxylase 1 |
increases expression |
ISO |
Diquat results in increased expression of BBOX1 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 3:96,822,654...96,871,786
Ensembl chr 3:96,822,655...96,871,458
|
|
G |
Bcas2 |
BCAS2, pre-mRNA processing factor |
decreases expression |
ISO |
Diquat results in decreased expression of BCAS2 protein |
CTD |
PMID:36851058 |
|
NCBI chr 2:190,692,503...190,700,386
Ensembl chr 2:190,692,461...190,700,389
|
|
G |
Bcat1 |
branched chain amino acid transaminase 1 |
decreases expression |
ISO |
Diquat results in decreased expression of BCAT1 mRNA; Diquat results in decreased expression of BCAT1 protein |
CTD |
PMID:36851058 |
|
NCBI chr 4:177,964,834...178,046,573
Ensembl chr 4:177,964,834...178,046,597
|
|
G |
Bcl10 |
BCL10, immune signaling adaptor |
decreases expression |
ISO |
Diquat results in decreased expression of BCL10 protein |
CTD |
PMID:36851058 |
|
NCBI chr 2:234,840,880...234,850,520
Ensembl chr 2:234,840,858...234,850,523
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
affects expression multiple interactions decreases expression |
ISO EXP |
Diquat affects the expression of BCL2 mRNA procyanidin B2 affects the reaction [Diquat affects the expression of BCL2 mRNA] Diquat results in decreased expression of BCL2 protein |
CTD |
PMID:26785375 PMID:27057282 PMID:29484840 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
increases expression |
ISO |
Diquat results in increased expression of BCL2L1 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
|
|
G |
Bcl2l11 |
Bcl2-like 11 |
increases expression multiple interactions |
ISO |
Diquat results in increased expression of BCL2L11 mRNA procyanidin B2 inhibits the reaction [Diquat results in increased expression of BCL2L11 mRNA] |
CTD |
PMID:26785375 PMID:27057282 |
|
NCBI chr 3:115,366,783...115,404,068
Ensembl chr 3:115,366,646...115,404,068
|
|
G |
Bcl6b |
BCL6B, transcription repressor |
decreases expression |
ISO |
Diquat results in decreased expression of BCL6B mRNA |
CTD |
PMID:36851058 |
|
NCBI chr10:54,940,908...54,947,022
Ensembl chr10:54,940,909...54,945,974
|
|
G |
Bdkrb2 |
bradykinin receptor B2 |
increases expression |
ISO |
Diquat results in increased expression of BDKRB2 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 6:124,472,317...124,502,497
Ensembl chr 6:124,472,566...124,502,497
|
|
G |
Becn1 |
beclin 1 |
multiple interactions |
ISO |
[Diquat co-treated with procyanidin B2] results in increased expression of BECN1 mRNA |
CTD |
PMID:27057282 |
|
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
|
|
G |
Bgn |
biglycan |
decreases expression |
ISO |
Diquat results in decreased expression of BGN mRNA |
CTD |
PMID:36851058 |
|
NCBI chr X:151,197,296...151,209,458
Ensembl chr X:151,197,273...151,209,461
|
|
G |
Bhmt |
betaine-homocysteine S-methyltransferase |
increases expression |
ISO |
Diquat results in increased expression of BHMT mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 2:24,859,871...24,879,449
Ensembl chr 2:24,859,873...24,879,742
|
|
G |
Bicd1 |
BICD cargo adaptor 1 |
decreases expression |
ISO |
Diquat results in decreased expression of BICD1 protein |
CTD |
PMID:36851058 |
|
NCBI chr 4:182,479,071...182,631,504
Ensembl chr 4:182,479,071...182,627,434
|
|
G |
Blvrb |
biliverdin reductase B |
increases expression |
ISO |
Diquat results in increased expression of BLVRB mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 1:82,738,646...82,756,312
Ensembl chr 1:82,738,695...82,770,375
|
|
G |
Bmp6 |
bone morphogenetic protein 6 |
increases expression |
ISO |
Diquat results in increased expression of BMP6 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr17:26,318,121...26,469,691
Ensembl chr17:26,318,569...26,470,365
|
|
G |
Bop1 |
BOP1 ribosomal biogenesis factor |
decreases expression |
ISO |
Diquat results in decreased expression of BOP1 protein |
CTD |
PMID:36851058 |
|
NCBI chr 7:108,172,062...108,195,875
Ensembl chr 7:108,172,066...108,195,931
|
|
G |
Brox |
BRO1 domain and CAAX motif containing |
increases expression |
ISO |
Diquat results in increased expression of BROX protein |
CTD |
PMID:36851058 |
|
NCBI chr13:94,920,107...94,940,189
Ensembl chr13:94,920,112...94,940,227
|
|
G |
Bst2 |
bone marrow stromal cell antigen 2 |
decreases expression |
ISO |
Diquat results in decreased expression of BST2 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr16:18,216,605...18,220,979
Ensembl chr16:18,217,407...18,220,979
|
|
G |
Btk |
Bruton tyrosine kinase |
decreases expression |
ISO |
Diquat results in decreased expression of BTK mRNA |
CTD |
PMID:36851058 |
|
NCBI chr X:97,722,796...97,762,315
Ensembl chr X:97,722,802...97,761,853
|
|
G |
Btnl9 |
butyrophilin-like 9 |
decreases expression |
ISO |
Diquat results in decreased expression of BTNL9 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr10:33,466,059...33,489,229
Ensembl chr10:33,470,536...33,489,025
|
|
G |
C1qtnf2 |
C1q and TNF related 2 |
decreases expression |
ISO |
Diquat results in decreased expression of C1QTNF2 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr10:27,941,948...27,958,926
Ensembl chr10:27,941,948...27,959,185
|
|
G |
C1qtnf3 |
C1q and TNF related 3 |
decreases expression |
ISO |
Diquat results in decreased expression of C1QTNF3 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 2:59,917,099...59,939,519
Ensembl chr 2:59,917,188...59,939,433
|
|
G |
C1s |
complement C1s |
decreases expression |
ISO |
Diquat results in decreased expression of C1S1 protein |
CTD |
PMID:36851058 |
|
NCBI chr 4:157,430,249...157,442,438
Ensembl chr 4:157,430,117...157,442,303
|
|
G |
C3 |
complement C3 |
increases expression |
ISO |
Diquat results in increased expression of C3 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
|
|
G |
C7 |
complement C7 |
decreases expression |
ISO |
Diquat results in decreased expression of C7 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 2:54,088,116...54,165,102
Ensembl chr 2:54,088,116...54,158,535
|
|
G |
C8a |
complement C8 alpha chain |
decreases expression |
ISO |
Diquat results in decreased expression of C8A mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 5:119,583,168...119,637,675
Ensembl chr 5:119,583,174...119,637,754
|
|
G |
Cadm3 |
cell adhesion molecule 3 |
decreases expression |
ISO |
Diquat results in decreased expression of CADM3 protein |
CTD |
PMID:36851058 |
|
NCBI chr13:85,784,785...85,817,412
Ensembl chr13:85,786,483...85,817,749
|
|
G |
Camlg |
calcium modulating ligand |
decreases expression |
ISO |
Diquat results in decreased expression of CAMLG protein |
CTD |
PMID:36851058 |
|
NCBI chr17:8,992,697...9,003,576
Ensembl chr17:8,992,696...9,003,552
|
|
G |
Capg |
capping actin protein, gelsolin like |
increases expression |
ISO |
Diquat results in increased expression of CAPG mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 4:104,594,743...104,611,856
Ensembl chr 4:104,594,753...104,611,856
|
|
G |
Car5a |
carbonic anhydrase 5A |
increases expression |
ISO |
Diquat results in increased expression of CAR5A mRNA |
CTD |
PMID:36851058 |
|
NCBI chr19:49,973,092...50,002,948
Ensembl chr19:49,973,107...50,002,906
|
|
G |
Card11 |
caspase recruitment domain family, member 11 |
decreases expression |
ISO |
Diquat results in decreased expression of CARD11 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr12:13,621,140...13,758,115
Ensembl chr12:13,621,087...13,758,112
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases cleavage increases expression |
ISO EXP |
Deferoxamine inhibits the reaction [Diquat results in increased cleavage of CASP3 protein]; Glutathione inhibits the reaction [Diquat results in increased cleavage of CASP3 protein]; GPX4 protein inhibits the reaction [Diquat results in increased cleavage of CASP3 protein] [Antioxidants results in decreased susceptibility to Diquat] which results in decreased expression of CASP3 mRNA; Diquat results in increased cleavage of and results in increased activity of CASP3 protein; procyanidin B2 inhibits the reaction [Diquat results in increased expression of CASP3 mRNA]; TXN2 protein affects the reaction [Diquat results in increased cleavage of and results in increased activity of CASP3 protein] Diquat results in increased expression of CASP3 mRNA; Diquat results in increased expression of CASP3 protein modified form Acetylcysteine inhibits the reaction [Diquat results in increased expression of CASP3 protein modified form]; Meloxicam inhibits the reaction [Diquat results in increased expression of CASP3 protein modified form]; pifithrin inhibits the reaction [Diquat results in increased expression of CASP3 protein modified form]; SN50 peptide inhibits the reaction [Diquat results in increased expression of CASP3 protein modified form] |
CTD |
PMID:15496407 PMID:18164269 PMID:19815060 PMID:26785375 PMID:27057282 PMID:29484840 PMID:32536062 PMID:38128689 More...
|
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp8 |
caspase 8 |
multiple interactions |
ISO |
[Antioxidants results in decreased susceptibility to Diquat] which results in decreased expression of CASP8 mRNA |
CTD |
PMID:32536062 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
multiple interactions increases cleavage increases expression |
ISO EXP |
Diquat results in increased cleavage of and results in increased activity of CASP9 protein; PROP1 protein affects the reaction [Diquat results in increased cleavage of CASP9 protein]; TXN2 protein affects the reaction [Diquat results in increased cleavage of and results in increased activity of CASP9 protein] Diquat results in increased expression of CASP9 protein modified form Meloxicam inhibits the reaction [Diquat results in increased expression of CASP9 protein modified form] |
CTD |
PMID:18164269 PMID:20826540 PMID:29484840 PMID:38128689 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
multiple interactions decreases activity decreases expression increases activity |
ISO EXP |
CAT protein inhibits the reaction [[POR protein results in increased metabolism of Diquat] which results in increased abundance of Hydrogen Peroxide] 3,4-dihydroxyphenylethanol inhibits the reaction [Diquat results in decreased activity of CAT protein]; 3,4-dihydroxyphenylethanol inhibits the reaction [Diquat results in decreased expression of CAT mRNA]; CAT protein inhibits the reaction [[POR protein results in increased metabolism of Diquat] which results in increased abundance of Hydrogen Peroxide]; procyanidin B2 inhibits the reaction [Diquat results in decreased activity of CAT protein] Diquat results in increased activity of CAT protein |
CTD |
PMID:21215309 PMID:26785375 PMID:27057282 PMID:36572071 PMID:37277018 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Catsper1 |
cation channel, sperm associated 1 |
increases expression |
ISO |
Diquat results in increased expression of CATSPER1 protein |
CTD |
PMID:36851058 |
|
NCBI chr 1:202,643,009...202,652,059
Ensembl chr 1:202,643,038...202,651,824
|
|
G |
Cbr1 |
carbonyl reductase 1 |
increases expression |
ISO |
Diquat results in increased expression of CBR1 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr11:32,860,571...32,862,981
Ensembl chr11:32,908,950...32,911,393 Ensembl chr11:32,908,950...32,911,393
|
|
G |
Cbr3 |
carbonyl reductase 3 |
increases expression |
ISO |
Diquat results in increased expression of CBR3 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr11:33,008,615...33,016,877
Ensembl chr11:33,008,615...33,016,875
|
|
G |
Cbx3 |
chromobox 3 |
increases expression |
ISO |
Diquat results in increased expression of CBX3 protein |
CTD |
PMID:36851058 |
|
NCBI chr 4:80,545,450...80,559,284
Ensembl chr 4:80,546,010...80,559,283
|
|
G |
Cbx8 |
chromobox 8 |
decreases expression |
ISO |
Diquat results in decreased expression of CBX8 protein |
CTD |
PMID:36851058 |
|
NCBI chr10:104,294,518...104,296,956
Ensembl chr10:104,294,518...104,297,024
|
|
G |
Ccdc115 |
coiled-coil domain containing 115 |
decreases expression |
ISO |
Diquat results in decreased expression of CCDC115 protein |
CTD |
PMID:36851058 |
|
NCBI chr 9:36,650,384...36,654,348
Ensembl chr 9:36,649,271...36,653,946
|
|
G |
Ccdc124 |
coiled-coil domain containing 124 |
decreases expression |
ISO |
Diquat results in decreased expression of CCDC124 protein |
CTD |
PMID:36851058 |
|
NCBI chr16:18,566,745...18,572,564
Ensembl chr16:18,566,745...18,572,564
|
|
G |
Ccdc167 |
coiled-coil domain containing 167 |
decreases expression |
ISO |
Diquat results in decreased expression of CCDC167 protein |
CTD |
PMID:36851058 |
|
NCBI chr20:7,763,927...7,782,090
Ensembl chr20:7,751,782...7,781,613
|
|
G |
Ccdc175 |
coiled-coil domain containing 175 |
increases expression |
ISO |
Diquat results in increased expression of CCDC175 protein |
CTD |
PMID:36851058 |
|
NCBI chr 6:90,661,948...90,745,015
Ensembl chr 6:90,662,269...90,744,963
|
|
G |
Ccdc180 |
coiled-coil domain containing 180 |
decreases expression |
ISO |
Diquat results in decreased expression of CCDC180 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 5:60,154,883...60,223,508
Ensembl chr 5:60,154,910...60,223,522
|
|
G |
Ccdc40 |
coiled-coil domain 40 molecular ruler complex subunit |
decreases expression |
ISO |
Diquat results in decreased expression of CCDC40 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr10:104,486,748...104,527,284
Ensembl chr10:104,486,748...104,527,243
|
|
G |
Ccdc80 |
coiled-coil domain containing 80 |
decreases expression |
ISO |
Diquat results in decreased expression of CCDC80 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr11:55,685,165...55,718,827
Ensembl chr11:55,685,872...55,719,137
|
|
G |
Ccdc85c |
coiled-coil domain containing 85C |
decreases expression |
ISO |
Diquat results in decreased expression of CCDC85C protein |
CTD |
PMID:36851058 |
|
NCBI chr 6:127,113,440...127,184,328
Ensembl chr 6:127,113,442...127,184,371
|
|
G |
Ccn2 |
cellular communication network factor 2 |
decreases expression |
ISO |
Diquat results in decreased expression of CCN2 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
|
|
G |
Ccna2 |
cyclin A2 |
decreases expression |
ISO |
Diquat results in decreased expression of CCNA2 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
|
|
G |
Ccnb1 |
cyclin B1 |
decreases expression |
ISO |
Diquat results in decreased expression of CCNB1 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Ccr7 |
C-C motif chemokine receptor 7 |
decreases expression |
ISO |
Diquat results in decreased expression of CCR7 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr10:84,098,193...84,108,309
Ensembl chr10:84,097,381...84,108,309
|
|
G |
Cd180 |
CD180 molecule |
decreases expression |
ISO |
Diquat results in decreased expression of CD180 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 2:33,855,940...33,870,046
Ensembl chr 2:33,855,991...33,899,936
|
|
G |
Cd22 |
CD22 molecule |
decreases expression |
ISO |
Diquat results in decreased expression of CD22 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 1:86,116,376...86,132,782
Ensembl chr 1:86,117,459...86,132,322
|
|
G |
Cd274 |
CD274 molecule |
decreases expression |
ISO |
Diquat results in decreased expression of CD274 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 1:227,116,674...227,137,379
Ensembl chr 1:227,116,649...227,134,450
|
|
G |
Cd28 |
Cd28 molecule |
decreases expression |
ISO |
Diquat results in decreased expression of CD28 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 9:62,166,324...62,194,674
Ensembl chr 9:62,166,192...62,194,685
|
|
G |
Cd300ld |
Cd300 molecule-like family member D |
decreases expression |
ISO |
Diquat results in decreased expression of CD300LD mRNA |
CTD |
PMID:36851058 |
|
NCBI chr10:100,082,957...100,115,853
Ensembl chr10:100,083,490...100,115,821
|
|
G |
Cd34 |
CD34 molecule |
decreases expression |
ISO |
Diquat results in decreased expression of CD34 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr13:106,480,313...106,500,844
Ensembl chr13:106,480,043...106,499,832
|
|
G |
Cd40 |
CD40 molecule |
decreases expression |
ISO |
Diquat results in decreased expression of CD40 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534
|
|
G |
Cd44 |
CD44 molecule |
decreases expression |
ISO |
Diquat results in decreased expression of CD44 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620
|
|
G |
Cd52 |
CD52 molecule |
decreases expression |
ISO |
Diquat results in decreased expression of CD52 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 5:146,319,789...146,321,348
Ensembl chr 5:146,319,969...146,321,348
|
|
G |
Cd53 |
Cd53 molecule |
decreases expression |
ISO |
Diquat results in decreased expression of CD53 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 2:194,352,139...194,399,668
Ensembl chr 2:194,352,139...194,399,657
|
|
G |
Cd5l |
Cd5 molecule-like |
decreases expression |
ISO |
Diquat results in decreased expression of CD5L protein |
CTD |
PMID:36851058 |
|
NCBI chr 2:172,791,007...172,802,018
Ensembl chr 2:172,790,934...172,829,753
|
|
G |
Cd72 |
Cd72 molecule |
decreases expression |
ISO |
Diquat results in decreased expression of CD72 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 5:57,697,361...57,704,980
Ensembl chr 5:57,697,367...57,704,725
|
|
G |
Cd74 |
CD74 molecule |
decreases expression |
ISO |
Diquat results in decreased expression of CD74 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr18:54,256,757...54,266,003
Ensembl chr18:54,256,778...54,266,003
|
|
G |
Cd81 |
Cd81 molecule |
increases expression |
ISO |
Diquat results in increased expression of CD81 protein |
CTD |
PMID:36851058 |
|
NCBI chr 1:198,235,861...198,251,660
Ensembl chr 1:198,241,484...198,251,660
|
|
G |
Cd82 |
Cd82 molecule |
increases expression |
ISO |
Diquat results in increased expression of CD82 protein |
CTD |
PMID:36851058 |
|
NCBI chr 3:79,387,361...79,431,847
Ensembl chr 3:79,385,887...79,431,809
|
|
G |
Cdc20 |
cell division cycle 20 |
decreases expression |
ISO |
Diquat results in decreased expression of CDC20 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 5:131,966,203...131,970,406
Ensembl chr 5:131,966,215...131,970,512
|
|
G |
Cdc34 |
cell division cycle 34, ubiqiutin conjugating enzyme |
increases expression |
ISO |
Diquat results in increased expression of CDC34 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 7:10,017,588...10,023,586
Ensembl chr 7:10,017,588...10,023,186
|
|
G |
Cdc37l1 |
cell division cycle 37-like 1 |
increases expression |
ISO |
Diquat results in increased expression of CDC37L1 protein |
CTD |
PMID:36851058 |
|
NCBI chr 1:226,705,019...226,733,994
Ensembl chr 1:226,705,003...226,761,175
|
|
G |
Cdh11 |
cadherin 11 |
decreases expression |
ISO |
Diquat results in decreased expression of CDH11 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr19:2,148,447...2,305,754
Ensembl chr19:2,148,458...2,304,272
|
|
G |
Cdk1 |
cyclin-dependent kinase 1 |
decreases expression |
ISO |
Diquat results in decreased expression of CDK1 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
|
|
G |
Cdk7 |
cyclin-dependent kinase 7 |
increases expression |
ISO |
Diquat results in increased expression of CDK7 protein |
CTD |
PMID:36851058 |
|
NCBI chr 2:31,840,558...31,865,422
Ensembl chr 2:31,840,558...31,865,383
|
|
G |
Cdkal1 |
CDK5 regulatory subunit associated protein 1-like 1 |
decreases expression |
ISO |
Diquat results in decreased expression of CDKAL1 protein |
CTD |
PMID:36851058 |
|
NCBI chr17:34,718,701...35,271,276
Ensembl chr17:34,718,687...35,407,524
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
increases expression |
ISO |
Diquat results in increased expression of CDKN1A mRNA |
CTD |
PMID:36851058 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cds1 |
CDP-diacylglycerol synthase 1 |
decreases expression |
ISO |
Diquat results in decreased expression of CDS1 protein |
CTD |
PMID:36851058 |
|
NCBI chr14:7,820,328...7,882,943
Ensembl chr14:7,820,351...7,882,681
|
|
G |
Cebpa |
CCAAT/enhancer binding protein alpha |
increases expression |
ISO |
Diquat results in increased expression of CEBPA mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 1:87,759,631...87,762,303
Ensembl chr 1:87,759,433...87,762,412
|
|
G |
Cebpb |
CCAAT/enhancer binding protein beta |
increases expression |
ISO |
Diquat results in increased expression of CEBPB mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 3:156,398,035...156,399,466
Ensembl chr 3:156,397,052...156,399,473
|
|
G |
Cemip2 |
cell migration inducing hyaluronidase 2 |
decreases expression |
ISO |
Diquat results in decreased expression of CEMIP2 protein |
CTD |
PMID:36851058 |
|
NCBI chr 1:219,330,295...219,407,760
Ensembl chr 1:219,337,985...219,407,760
|
|
G |
Cenpe |
centromere protein E |
decreases expression |
ISO |
Diquat results in decreased expression of CENPE mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 2:223,637,035...223,695,692
Ensembl chr 2:223,636,998...223,695,669
|
|
G |
Cenpf |
centromere protein F |
decreases expression |
ISO |
Diquat results in decreased expression of CENPF mRNA |
CTD |
PMID:36851058 |
|
NCBI chr13:101,184,127...101,229,714
Ensembl chr13:101,184,127...101,229,669
|
|
G |
Ces2h |
carboxylesterase 2H |
decreases expression |
ISO |
Diquat results in decreased expression of CES2H mRNA |
CTD |
PMID:36851058 |
|
NCBI chr19:32,974,242...32,988,842
Ensembl chr19:32,974,242...32,988,830
|
|
G |
Cfap20 |
cilia and flagella associated protein 20 |
decreases expression |
ISO |
Diquat results in decreased expression of CFAP20 protein |
CTD |
PMID:36851058 |
|
NCBI chr19:9,608,867...9,622,558
Ensembl chr19:9,608,859...9,622,558
|
|
G |
Cfap70 |
cilia and flagella associated protein 70 |
decreases expression |
ISO |
Diquat results in decreased expression of CFAP70 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr15:3,852,381...3,918,036
Ensembl chr15:3,852,509...3,918,014
|
|
G |
Cfb |
complement factor B |
decreases expression |
ISO |
Diquat results in decreased expression of CFB mRNA |
CTD |
PMID:36851058 |
|
NCBI chr20:3,970,643...3,976,510
Ensembl chr20:3,951,474...3,976,505
|
|
G |
Cfh |
complement factor H |
decreases expression |
ISO |
Diquat results in decreased expression of CFH mRNA |
CTD |
PMID:36851058 |
|
NCBI chr13:51,512,376...51,613,829
Ensembl chr13:51,511,828...51,613,838
|
|
G |
Chchd1 |
coiled-coil-helix-coiled-coil-helix domain containing 1 |
decreases expression |
ISO |
Diquat results in decreased expression of CHCHD1 protein |
CTD |
PMID:36851058 |
|
NCBI chr15:3,592,719...3,593,901
Ensembl chr15:3,592,727...3,593,901
|
|
G |
Chchd10 |
coiled-coil-helix-coiled-coil-helix domain containing 10 |
increases expression |
ISO |
Diquat results in increased expression of CHCHD10 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr20:12,725,839...12,727,638
Ensembl chr20:12,725,842...12,732,763
|
|
G |
Chchd2 |
coiled-coil-helix-coiled-coil-helix domain containing 2 |
decreases expression |
ISO |
Diquat results in decreased expression of CHCHD2 protein |
CTD |
PMID:36851058 |
|
NCBI chr12:26,828,738...26,834,762
Ensembl chr12:26,828,736...26,834,755
|
|
G |
Chp1 |
calcineurin-like EF-hand protein 1 |
increases expression |
ISO |
Diquat results in increased expression of CHP1 protein |
CTD |
PMID:36851058 |
|
NCBI chr 3:106,536,009...106,571,255
Ensembl chr 3:106,536,004...106,571,251
|
|
G |
Chrdl2 |
chordin-like 2 |
increases expression |
ISO |
Diquat results in increased expression of CHRDL2 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 1:154,343,201...154,370,651
Ensembl chr 1:154,343,201...154,370,640
|
|
G |
Chrna2 |
cholinergic receptor nicotinic alpha 2 subunit |
increases expression |
ISO |
Diquat results in increased expression of CHRNA2 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr15:40,342,317...40,358,601
Ensembl chr15:40,342,317...40,358,601
|
|
G |
Chst13 |
carbohydrate sulfotransferase 13 |
increases expression |
ISO |
Diquat results in increased expression of CHST13 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 4:122,824,022...122,837,940
Ensembl chr 4:122,824,022...122,838,019
|
|
G |
Chst2 |
carbohydrate sulfotransferase 2 |
decreases expression |
ISO |
Diquat results in decreased expression of CHST2 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 8:95,960,067...95,966,312
Ensembl chr 8:95,959,826...95,966,955
|
|
G |
Chuk |
component of inhibitor of nuclear factor kappa B kinase complex |
increases expression |
EXP |
Diquat results in increased expression of CHUK protein |
CTD |
PMID:37277018 |
|
NCBI chr 1:242,959,539...242,995,066
Ensembl chr 1:242,959,760...242,995,065
|
|
G |
Cidec |
cell death-inducing DFFA-like effector c |
increases expression |
ISO |
Diquat results in increased expression of CIDEC mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 4:146,569,288...146,582,173
Ensembl chr 4:146,569,289...146,582,173
|
|
G |
Cited4 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4 |
increases expression |
ISO |
Diquat results in increased expression of CITED4 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 5:134,246,936...134,247,827
Ensembl chr 5:134,246,682...134,248,135
|
|
G |
Ckap2 |
cytoskeleton associated protein 2 |
decreases expression |
ISO |
Diquat results in decreased expression of CKAP2 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr16:69,839,668...69,864,852
Ensembl chr16:69,839,630...69,864,913
|
|
G |
Ckap2l |
cytoskeleton associated protein 2-like |
decreases expression |
ISO |
Diquat results in decreased expression of CKAP2L mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 3:116,497,186...116,524,302
Ensembl chr 3:116,498,022...116,524,366
|
|
G |
Clcf1 |
cardiotrophin-like cytokine factor 1 |
increases expression |
ISO |
Diquat results in increased expression of CLCF1 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 1:201,507,763...201,517,607
Ensembl chr 1:201,507,859...201,517,605
|
|
G |
Clcn4 |
chloride voltage-gated channel 4 |
decreases expression |
ISO |
Diquat results in decreased expression of CLCN4 protein |
CTD |
PMID:36851058 |
|
NCBI chr X:23,729,194...23,795,391
Ensembl chr X:23,729,338...23,793,238
|
|
G |
Cldn14 |
claudin 14 |
increases expression |
ISO |
Diquat results in increased expression of CLDN14 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr11:33,232,281...33,329,440
Ensembl chr11:33,232,220...33,329,171
|
|
G |
Cldn18 |
claudin 18 |
decreases expression |
ISO |
Diquat results in decreased expression of CLDN18 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 8:100,246,499...100,265,797
Ensembl chr 8:100,247,633...100,273,351
|
|
G |
Cldn4 |
claudin 4 |
increases expression |
ISO |
Diquat results in increased expression of CLDN4 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr12:21,751,638...21,753,436
Ensembl chr12:21,751,331...21,753,436
|
|
G |
Cldn8 |
claudin 8 |
increases expression |
ISO |
Diquat results in increased expression of CLDN8 protein |
CTD |
PMID:36851058 |
|
NCBI chr11:27,875,857...27,878,106
Ensembl chr11:27,875,692...27,878,513
|
|
G |
Clec12a |
C-type lectin domain family 12, member A |
decreases expression |
ISO |
Diquat results in decreased expression of CLEC12A mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 4:162,798,125...162,816,757
Ensembl chr 4:162,798,125...162,816,753
|
|
G |
Clec3b |
C-type lectin domain family 3, member B |
decreases expression |
ISO |
Diquat results in decreased expression of CLEC3B protein |
CTD |
PMID:36851058 |
|
NCBI chr 8:122,810,120...122,815,837
Ensembl chr 8:122,810,149...122,815,835
|
|
G |
Clec9a |
C-type lectin domain containing 9A |
decreases expression |
ISO |
Diquat results in decreased expression of CLEC9A mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 4:162,859,742...162,875,742
Ensembl chr 4:162,860,308...162,875,352
|
|
G |
Clip4 |
CAP-GLY domain containing linker protein family, member 4 |
increases expression |
ISO |
Diquat results in increased expression of CLIP4 mRNA |
CTD |
PMID:21172416 |
|
NCBI chr 6:23,616,280...23,697,625 NCBI chr 6:23,718,580...23,729,231 NCBI chr 6:23,597,729...23,601,000
Ensembl chr 6:23,616,281...23,677,874
|
|
G |
Clk3 |
CDC-like kinase 3 |
increases expression |
ISO |
Diquat results in increased expression of CLK3 protein |
CTD |
PMID:36851058 |
|
NCBI chr 8:58,152,155...58,167,196
Ensembl chr 8:58,152,155...58,168,181
|
|
G |
Clspn |
claspin |
decreases expression |
ISO |
Diquat results in decreased expression of CLSPN mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 5:138,850,119...138,885,037
Ensembl chr 5:138,850,128...138,885,034
|
|
G |
Clstn2 |
calsyntenin 2 |
decreases expression |
ISO |
Diquat results in decreased expression of CLSTN2 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 8:98,020,406...98,637,232
Ensembl chr 8:98,021,666...98,637,731
|
|
G |
Cltrn |
collectrin, amino acid transport regulator |
decreases expression |
ISO |
Diquat results in decreased expression of CLTRN protein |
CTD |
PMID:36851058 |
|
NCBI chr X:30,361,967...30,395,264
Ensembl chr X:30,361,967...30,395,349
|
|
G |
Cmip |
c-Maf-inducing protein |
decreases expression |
ISO |
Diquat results in decreased expression of CMIP protein |
CTD |
PMID:36851058 |
|
NCBI chr19:45,304,597...45,510,653
Ensembl chr19:45,304,031...45,508,709
|
|
G |
Cmtm3 |
CKLF-like MARVEL transmembrane domain containing 3 |
decreases expression |
ISO |
Diquat results in decreased expression of CMTM3 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr19:622,563...630,721
Ensembl chr19:604,458...629,790
|
|
G |
Cndp2 |
carnosine dipeptidase 2 |
decreases expression |
ISO |
Diquat results in decreased expression of CNDP2 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr18:78,039,924...78,057,030
Ensembl chr18:78,039,932...78,056,922
|
|
G |
Cnn1 |
calponin 1 |
decreases expression |
ISO |
Diquat results in decreased expression of CNN1 protein |
CTD |
PMID:36851058 |
|
NCBI chr 8:20,632,434...20,641,097
Ensembl chr 8:20,632,338...20,641,098
|
|
G |
Cnnm4 |
cyclin and CBS domain divalent metal cation transport mediator 4 |
increases expression |
ISO |
Diquat results in increased expression of CNNM4 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 9:38,711,726...38,750,942
Ensembl chr 9:38,711,710...38,750,942
|
|
G |
Cnot7 |
CCR4-NOT transcription complex, subunit 7 |
increases expression |
ISO |
Diquat results in increased expression of CNOT7 protein |
CTD |
PMID:36851058 |
|
NCBI chr16:51,775,416...51,794,581
Ensembl chr16:51,775,412...51,794,576
|
|
G |
Cnrip1 |
cannabinoid receptor interacting protein 1 |
decreases expression |
ISO |
Diquat results in decreased expression of CNRIP1 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr14:91,462,877...91,492,739
Ensembl chr14:91,462,647...91,492,735
|
|
G |
Cntn1 |
contactin 1 |
decreases expression |
ISO |
Diquat results in decreased expression of CNTN1 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 7:123,263,146...123,560,896
Ensembl chr 7:123,372,792...123,558,541
|
|
G |
Cntn5 |
contactin 5 |
decreases expression |
ISO |
Diquat results in decreased expression of CNTN5 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 8:6,735,715...7,967,727
Ensembl chr 8:6,738,239...7,967,957
|
|
G |
Cntnap5b |
contactin associated protein family member 5B |
decreases expression |
ISO |
Diquat results in decreased expression of CNTNAP5A mRNA |
CTD |
PMID:36851058 |
|
NCBI chr13:17,863,367...18,766,983
Ensembl chr13:18,093,420...18,761,014
|
|
G |
Col13a1 |
collagen type XIII alpha 1 chain |
increases expression |
ISO |
Diquat results in increased expression of COL13A1 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr20:29,783,965...29,924,116
Ensembl chr20:29,783,965...29,924,032
|
|
G |
Col14a1 |
collagen type XIV alpha 1 chain |
decreases expression |
ISO |
Diquat results in decreased expression of COL14A1 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 7:86,722,093...86,937,215
Ensembl chr 7:86,722,094...86,937,214
|
|
G |
Col15a1 |
collagen type XV alpha 1 chain |
decreases expression |
ISO |
Diquat results in decreased expression of COL15A1 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 5:61,501,963...61,607,591
Ensembl chr 5:61,501,963...61,607,591
|
|
G |
Col19a1 |
collagen type XIX alpha 1 chain |
decreases expression |
ISO |
Diquat results in decreased expression of COL19A1 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 9:26,673,916...27,022,139
Ensembl chr 9:26,675,391...27,022,106
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
decreases expression |
ISO |
Diquat results in decreased expression of COL1A1 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
|
|
G |
Col1a2 |
collagen type I alpha 2 chain |
decreases expression |
ISO |
Diquat results in decreased expression of COL1A2 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 4:32,563,938...32,598,868
Ensembl chr 4:32,563,381...32,598,867
|
|
G |
Col3a1 |
collagen type III alpha 1 chain |
decreases expression |
ISO |
Diquat results in decreased expression of COL3A1 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 9:47,374,611...47,410,547
Ensembl chr 9:47,374,593...47,410,547
|
|
G |
Col5a1 |
collagen type V alpha 1 chain |
decreases expression |
ISO |
Diquat results in decreased expression of COL5A1 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 3:11,208,429...11,356,715
Ensembl chr 3:11,208,512...11,354,588
|
|
G |
Col5a2 |
collagen type V alpha 2 chain |
decreases expression |
ISO |
Diquat results in decreased expression of COL5A2 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 9:47,448,741...47,598,134
Ensembl chr 9:47,448,736...47,598,154
|
|
G |
Col6a3 |
collagen type VI alpha 3 chain |
decreases expression |
ISO |
Diquat results in decreased expression of COL6A3 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 9:91,361,578...91,439,434
Ensembl chr 9:91,361,583...91,439,471
|
|
G |
Col6a6 |
collagen type VI alpha 6 chain |
decreases expression |
ISO |
Diquat results in decreased expression of COL6A6 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 8:106,318,010...106,473,419
Ensembl chr 8:106,306,422...106,473,472
|
|
G |
Colec11 |
collectin sub-family member 11 |
decreases expression |
ISO |
Diquat results in decreased expression of COLEC11 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 6:45,223,974...45,256,640
Ensembl chr 6:45,223,980...45,271,145
|
|
G |
Colec12 |
collectin sub-family member 12 |
decreases expression |
ISO |
Diquat results in decreased expression of COLEC12 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr18:732,950...920,620
Ensembl chr18:732,950...920,618
|
|
G |
Coro1a |
coronin 1A |
decreases expression |
ISO |
Diquat results in decreased expression of CORO1A mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 1:181,295,561...181,300,566
Ensembl chr 1:181,295,562...181,300,534
|
|
G |
Cotl1 |
coactosin-like F-actin binding protein 1 |
increases expression |
ISO |
Diquat results in increased expression of COTL1 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr19:47,871,689...47,906,010
Ensembl chr19:47,871,694...47,911,689
|
|
G |
Cox20 |
cytochrome c oxidase assembly factor COX20 |
decreases expression |
ISO |
Diquat results in decreased expression of COX20 protein |
CTD |
PMID:36851058 |
|
NCBI chr13:90,065,900...90,075,386
|
|
G |
Cox4i1 |
cytochrome c oxidase subunit 4i1 |
decreases expression |
ISO |
Diquat results in decreased expression of COX4I1 protein |
CTD |
PMID:36851058 |
|
NCBI chr19:48,721,680...48,727,920
Ensembl chr19:48,721,199...48,727,921
|
|
G |
Cox6b2 |
cytochrome c oxidase subunit 6B2 |
increases expression |
ISO |
Diquat results in increased expression of COX6B2 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 1:69,094,009...69,095,312
|
|
G |
Cpm |
carboxypeptidase M |
decreases expression |
ISO |
Diquat results in decreased expression of CPM mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 7:53,225,647...53,286,220
Ensembl chr 7:53,225,696...53,286,220
|
|
G |
Cpsf7 |
cleavage and polyadenylation specific factor 7 |
decreases expression |
ISO |
Diquat results in decreased expression of CPSF7 protein |
CTD |
PMID:36851058 |
|
NCBI chr 1:207,167,690...207,191,938
Ensembl chr 1:207,167,859...207,191,905
|
|
G |
Cpt2 |
carnitine palmitoyltransferase 2 |
increases expression |
ISO |
Diquat results in increased expression of CPT2 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 5:122,664,677...122,682,126
Ensembl chr 5:122,664,677...122,682,095
|
|
G |
Cpxm1 |
carboxypeptidase X (M14 family), member 1 |
decreases expression |
ISO |
Diquat results in decreased expression of CPXM1 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 3:117,588,532...117,595,330
Ensembl chr 3:117,588,532...117,595,330
|
|
G |
Cradd |
CASP2 and RIPK1 domain containing adaptor with death domain |
decreases expression |
ISO |
Diquat results in decreased expression of CRADD protein |
CTD |
PMID:36851058 |
|
NCBI chr 7:29,940,240...29,952,907
Ensembl chr 7:29,798,586...29,952,907
|
|
G |
Creb3l3 |
cAMP responsive element binding protein 3-like 3 |
increases expression |
ISO |
Diquat results in increased expression of CREB3L3 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 7:8,622,614...8,631,053
Ensembl chr 7:8,622,614...8,631,048
|
|
G |
Creg1 |
cellular repressor of E1A-stimulated genes 1 |
increases expression |
ISO |
Diquat results in increased expression of CREG1 mRNA; Diquat results in increased expression of CREG1 protein |
CTD |
PMID:36851058 |
|
NCBI chr13:78,019,814...78,032,310
Ensembl chr13:78,019,843...78,032,308
|
|
G |
Creld1 |
cysteine-rich with EGF-like domains 1 |
increases expression |
ISO |
Diquat results in increased expression of CRELD1 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 4:146,631,883...146,641,493
Ensembl chr 4:146,631,883...146,641,499
|
|
G |
Creld2 |
cysteine-rich with EGF-like domains 2 |
increases expression |
ISO |
Diquat results in increased expression of CRELD2 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 7:119,909,626...119,916,556
Ensembl chr 7:119,909,633...119,916,543
|
|
G |
Crppa |
CDP-L-ribitol pyrophosphorylase A |
decreases expression |
ISO |
Diquat results in decreased expression of CRPPA mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 6:53,120,264...53,397,030
Ensembl chr 6:53,121,438...53,397,028
|
|
G |
Cryaa |
crystallin, alpha A |
decreases expression |
ISO |
Diquat results in decreased expression of CRYAA mRNA |
CTD |
PMID:36851058 |
|
NCBI chr20:9,783,605...9,787,351
Ensembl chr20:9,783,605...9,787,349
|
|
G |
Crybg2 |
crystallin beta-gamma domain containing 2 |
increases expression |
ISO |
Diquat results in increased expression of CRYBG2 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 5:146,286,406...146,318,417
Ensembl chr 5:146,286,925...146,323,666
|
|
G |
Csgalnact1 |
chondroitin sulfate N-acetylgalactosaminyltransferase 1 |
decreases expression |
ISO |
Diquat results in decreased expression of CSGALNACT1 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr16:20,995,210...21,330,586
Ensembl chr16:21,235,784...21,330,319
|
|
G |
Csrp1 |
cysteine and glycine-rich protein 1 |
increases expression |
ISO |
Diquat results in increased expression of CSRP1 protein |
CTD |
PMID:36851058 |
|
NCBI chr13:47,158,171...47,179,388
Ensembl chr13:47,167,789...47,179,384
|
|
G |
Ctcfl1 |
CCCTC-binding factor like 1 |
increases expression |
ISO |
Diquat results in increased expression of CTCFL mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 3:161,868,306...161,890,949
Ensembl chr 3:161,868,306...161,890,949
|
|
G |
Ctnna2 |
catenin alpha 2 |
decreases expression |
ISO |
Diquat results in decreased expression of CTNNA2 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 4:109,294,249...110,443,409
Ensembl chr 4:109,293,978...110,443,522
|
|
G |
Ctss |
cathepsin S |
decreases expression |
ISO |
Diquat results in decreased expression of CTSS mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 2:183,086,437...183,114,483
Ensembl chr 2:183,086,437...183,114,483
|
|
G |
Cwf19l1 |
CWF19 like cell cycle control factor 1 |
increases expression |
ISO |
Diquat results in increased expression of CWF19L1 protein |
CTD |
PMID:36851058 |
|
NCBI chr 1:242,997,720...243,020,989
Ensembl chr 1:242,997,726...243,020,961
|
|
G |
Cx3cr1 |
C-X3-C motif chemokine receptor 1 |
decreases expression |
ISO |
Diquat results in decreased expression of CX3CR1 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 8:119,785,726...119,799,431
Ensembl chr 8:119,782,595...119,800,014
|
|
G |
Cxadr |
CXADR, Ig-like cell adhesion molecule |
decreases expression |
ISO |
Diquat results in decreased expression of CXADR protein |
CTD |
PMID:36851058 |
|
NCBI chr11:16,982,864...17,030,078
Ensembl chr11:16,982,860...17,030,046
|
|
G |
Cxcl14 |
C-X-C motif chemokine ligand 14 |
decreases expression |
ISO |
Diquat results in decreased expression of CXCL14 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr17:8,317,930...8,325,956
Ensembl chr17:8,317,933...8,324,839
|
|
G |
Cxcl3 |
C-X-C motif chemokine ligand 3 |
increases expression |
ISO |
Diquat results in increased expression of CXCL1 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511
|
|
G |
Cxcl9 |
C-X-C motif chemokine ligand 9 |
decreases expression |
ISO |
Diquat results in decreased expression of CXCL9 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr14:15,722,868...15,727,779
Ensembl chr14:15,722,908...15,728,435
|
|
G |
Cyb5b |
cytochrome b5 type B |
increases expression |
ISO |
Diquat results in increased expression of CYB5B protein |
CTD |
PMID:36851058 |
|
NCBI chr19:35,062,871...35,096,741
Ensembl chr19:35,062,813...35,098,249
|
|
G |
Cybb |
cytochrome b-245 beta chain |
decreases expression |
ISO |
Diquat results in decreased expression of CYBB mRNA |
CTD |
PMID:36851058 |
|
NCBI chr X:13,358,101...13,392,570
Ensembl chr X:13,359,430...13,392,586
|
|
G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
increases expression |
ISO |
Diquat results in increased expression of CYP17A1 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 1:245,535,462...245,543,148
Ensembl chr 1:245,535,462...245,541,573
|
|
G |
Cyp26b1 |
cytochrome P450, family 26, subfamily b, polypeptide 1 |
increases expression |
ISO |
Diquat results in increased expression of CYP26B1 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 4:117,041,808...117,058,628
Ensembl chr 4:117,041,808...117,058,628
|
|
G |
Cyp27a1 |
cytochrome P450, family 27, subfamily a, polypeptide 1 |
increases expression |
ISO |
Diquat results in increased expression of CYP27A1 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 9:76,264,655...76,294,551
Ensembl chr 9:76,264,860...76,294,551
|
|
G |
Cyp27b1 |
cytochrome P450, family 27, subfamily b, polypeptide 1 |
increases expression |
ISO |
Diquat results in increased expression of CYP27B1 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 7:62,869,340...62,876,242
Ensembl chr 7:62,871,297...62,876,241
|
|
G |
Cyp2a3 |
cytochrome P450, family 2, subfamily a, polypeptide 3 |
decreases expression |
ISO |
Diquat results in decreased expression of CYP2A4 protein |
CTD |
PMID:36851058 |
|
NCBI chr 1:82,171,914...82,179,980
Ensembl chr 1:82,169,949...82,179,979
|
|
G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
increases expression |
ISO |
Diquat results in increased expression of CYP2B10 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
|
|
G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
increases expression |
ISO |
Diquat results in increased expression of CYP2D22 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
|
|
G |
Cyp2f4 |
cytochrome P450, family 2, subfamily f, polypeptide 4 |
increases expression |
ISO |
Diquat results in increased expression of CYP2F2 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 1:82,416,107...82,429,897
Ensembl chr 1:82,416,130...82,429,896
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
decreases expression |
EXP |
Diquat results in decreased expression of CYP3A2 mRNA |
CTD |
PMID:7676460 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Cyp4a1 |
cytochrome P450, family 4, subfamily a, polypeptide 1 |
increases expression |
EXP |
Diquat results in increased expression of CYP4A1 mRNA |
CTD |
PMID:7676460 |
|
NCBI chr 5:129,123,323...129,137,464
Ensembl chr 5:129,123,336...129,137,464
|
|
G |
Cyp51 |
cytochrome P450, family 51 |
decreases expression |
ISO |
Diquat results in decreased expression of CYP51 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 4:30,036,956...30,055,410
Ensembl chr 4:30,036,865...30,055,410
|
|
G |
Cyth4 |
cytohesin 4 |
decreases expression |
ISO |
Diquat results in decreased expression of CYTH4 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 7:110,152,232...110,176,726
Ensembl chr 7:110,152,272...110,176,741
|
|
G |
Dact1 |
dishevelled-binding antagonist of beta-catenin 1 |
decreases expression |
ISO |
Diquat results in decreased expression of DACT1 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 6:89,790,676...89,818,254
Ensembl chr 6:89,790,644...89,817,906
|
|
G |
Dao |
D-amino-acid oxidase |
multiple interactions increases activity |
ISO |
Ascorbic Acid inhibits the reaction [Diquat results in increased activity of DAO protein] |
CTD |
PMID:33475796 |
|
NCBI chr12:42,592,342...42,613,046
Ensembl chr12:42,592,343...42,612,741
|
|
G |
Dcaf8 |
DDB1 and CUL4 associated factor 8 |
decreases expression |
ISO |
Diquat results in decreased expression of DCAF8 protein |
CTD |
PMID:36851058 |
|
NCBI chr13:84,609,838...84,667,025
Ensembl chr13:84,610,248...84,669,726
|
|
G |
Dchs1 |
dachsous cadherin-related 1 |
decreases expression |
ISO |
Diquat results in decreased expression of DCHS1 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 1:160,104,931...160,138,958
Ensembl chr 1:160,104,931...160,124,808
|
|
G |
Dclk2 |
doublecortin-like kinase 2 |
decreases expression |
ISO |
Diquat results in decreased expression of DCLK2 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 2:172,202,733...172,338,411
Ensembl chr 2:172,208,706...172,338,250
|
|
G |
Dcst1 |
DC-STAMP domain containing 1 |
decreases expression |
ISO |
Diquat results in decreased expression of DCST1 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 2:174,765,203...174,784,023
Ensembl chr 2:174,765,350...174,781,806
|
|
G |
Dctn6 |
dynactin subunit 6 |
decreases expression |
ISO |
Diquat results in decreased expression of DCTN6 protein |
CTD |
PMID:36851058 |
|
NCBI chr16:58,077,595...58,096,604
Ensembl chr16:58,077,585...58,096,968
|
|
G |
Ddc |
dopa decarboxylase |
increases expression |
ISO |
Diquat results in increased expression of DDC mRNA |
CTD |
PMID:36851058 |
|
NCBI chr14:86,378,685...86,469,189
Ensembl chr14:86,378,685...86,469,208
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
increases expression multiple interactions |
ISO |
Diquat results in increased expression of DDIT3 mRNA; Diquat results in increased expression of DDIT3 protein PROP1 protein affects the reaction [Diquat results in increased expression of DDIT3 mRNA]; PROP1 protein affects the reaction [Diquat results in increased expression of DDIT3 protein] |
CTD |
PMID:20826540 PMID:36851058 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Ddr2 |
discoidin domain receptor tyrosine kinase 2 |
decreases expression |
ISO |
Diquat results in decreased expression of DDR2 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr13:82,193,623...82,318,229
Ensembl chr13:82,195,463...82,317,363
|
|
G |
Ddx4 |
DEAD-box helicase 4 |
decreases expression |
ISO |
Diquat results in decreased expression of DDX4 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 2:44,227,946...44,282,867
Ensembl chr 2:44,227,946...44,282,723
|
|
G |
Ddx49 |
DEAD-box helicase 49 |
decreases expression |
ISO |
Diquat results in decreased expression of DDX49 protein |
CTD |
PMID:36851058 |
|
NCBI chr16:19,125,388...19,133,042
Ensembl chr16:19,125,384...19,133,616
|
|
G |
Decr2 |
2,4-dienoyl-CoA reductase 2 |
increases expression |
ISO |
Diquat results in increased expression of DECR2 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr10:15,104,907...15,113,281
Ensembl chr10:15,002,926...15,118,479
|
|
G |
Defb24 |
defensin beta 24 |
decreases expression |
ISO |
Diquat results in decreased expression of DEFB19 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 3:141,046,571...141,052,706
Ensembl chr 3:141,046,564...141,052,753
|
|
G |
Depdc5 |
DEP domain containing 5, GATOR1 subcomplex subunit |
decreases expression |
ISO |
Diquat results in decreased expression of DEPDC5 protein |
CTD |
PMID:36851058 |
|
NCBI chr14:77,732,297...77,862,924
Ensembl chr14:77,732,297...77,862,794
|
|
G |
Depp1 |
DEPP autophagy regulator 1 |
increases expression |
ISO |
Diquat results in increased expression of DEPP1 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 4:149,910,794...149,913,013
Ensembl chr 4:149,910,779...149,914,542
|
|
G |
Dgat2 |
diacylglycerol O-acyltransferase 2 |
increases expression |
ISO |
Diquat results in increased expression of DGAT2 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 1:153,454,078...153,484,432
Ensembl chr 1:153,454,080...153,484,428
|
|
G |
Dhcr7 |
7-dehydrocholesterol reductase |
decreases expression |
ISO |
Diquat results in decreased expression of DHCR7 protein |
CTD |
PMID:36851058 |
|
NCBI chr 1:199,015,081...199,031,055
Ensembl chr 1:199,015,081...199,031,055
|
|
G |
Dkk1 |
dickkopf WNT signaling pathway inhibitor 1 |
increases expression |
ISO |
Diquat results in increased expression of DKK1 mRNA |
CTD |
PMID:21172416 |
|
NCBI chr 1:228,381,521...228,385,202
Ensembl chr 1:228,381,521...228,385,202
|
|
G |
Dkk2 |
dickkopf WNT signaling pathway inhibitor 2 |
decreases expression |
ISO |
Diquat results in decreased expression of DKK2 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 2:220,568,338...220,660,225
Ensembl chr 2:220,568,338...220,660,225
|
|
G |
Dlg4 |
discs large MAGUK scaffold protein 4 |
decreases expression |
ISO |
Diquat results in decreased expression of DLG4 protein |
CTD |
PMID:36851058 |
|
NCBI chr10:54,740,700...54,769,097
Ensembl chr10:54,739,470...54,767,153
|
|
G |
Dll4 |
delta like canonical Notch ligand 4 |
decreases expression |
ISO |
Diquat results in decreased expression of DLL4 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 3:106,317,114...106,327,004
Ensembl chr 3:106,316,986...106,326,931
|
|
G |
Dnah17 |
dynein, axonemal, heavy chain 17 |
increases expression |
ISO |
Diquat results in increased expression of DNAH17 protein |
CTD |
PMID:36851058 |
|
NCBI chr10:103,244,144...103,364,953
Ensembl chr10:103,249,363...103,364,901
|
|
G |
Dnaja3 |
DnaJ heat shock protein family (Hsp40) member A3 |
decreases expression |
ISO |
Diquat results in decreased expression of DNAJA3 protein |
CTD |
PMID:36851058 |
|
NCBI chr10:10,854,732...10,880,171
Ensembl chr10:10,854,732...10,880,161
|
|
G |
Dnajb14 |
DnaJ heat shock protein family (Hsp40) member B14 |
increases expression |
ISO |
Diquat results in increased expression of DNAJB14 protein |
CTD |
PMID:36851058 |
|
NCBI chr 2:226,358,988...226,409,461
Ensembl chr 2:226,358,996...226,402,490
|
|
G |
Dnajc15 |
DnaJ heat shock protein family (Hsp40) member C15 |
decreases expression |
ISO |
Diquat results in decreased expression of DNAJC15 protein |
CTD |
PMID:36851058 |
|
NCBI chr15:53,182,060...53,249,675
Ensembl chr15:53,184,855...53,249,675
|
|
G |
Dnajc5 |
DnaJ heat shock protein family (Hsp40) member C5 |
increases expression |
ISO |
Diquat results in increased expression of DNAJC5 protein |
CTD |
PMID:36851058 |
|
NCBI chr 3:168,621,905...168,656,570
Ensembl chr 3:168,621,969...168,655,935
|
|
G |
Dnph1 |
2'-deoxynucleoside 5'-phosphate N-hydrolase 1 |
decreases expression |
ISO |
Diquat results in decreased expression of DNPH1 protein |
CTD |
PMID:36851058 |
|
NCBI chr 9:14,481,296...14,484,034
Ensembl chr 9:14,481,066...14,484,022
|
|
G |
Dock2 |
dedicator of cytokinesis 2 |
decreases expression |
ISO |
Diquat results in decreased expression of DOCK2 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr10:18,827,237...19,244,832
Ensembl chr10:18,827,239...19,244,808
|
|
G |
Dock4 |
dedicator of cytokinesis 4 |
increases expression |
ISO |
Diquat results in increased expression of DOCK4 protein |
CTD |
PMID:36851058 |
|
NCBI chr 6:57,512,929...57,902,597
Ensembl chr 6:57,512,908...57,901,855
|
|
G |
Dpt |
dermatopontin |
decreases expression |
ISO |
Diquat results in decreased expression of DPT mRNA |
CTD |
PMID:36851058 |
|
NCBI chr13:77,123,224...77,151,646
Ensembl chr13:77,123,115...77,151,639
|
|
G |
Dpys |
dihydropyrimidinase |
increases expression |
ISO |
Diquat results in increased expression of DPYS mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 7:70,822,648...70,929,255
Ensembl chr 7:70,835,789...70,929,231
|
|
G |
Dpysl3 |
dihydropyrimidinase-like 3 |
decreases expression |
ISO |
Diquat results in decreased expression of DPYSL3 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr18:35,374,427...35,480,228
Ensembl chr18:35,377,181...35,480,157
|
|
G |
Dsel |
dermatan sulfate epimerase-like |
decreases expression |
ISO |
Diquat results in decreased expression of DSEL mRNA |
CTD |
PMID:36851058 |
|
NCBI chr13:186,413...192,592
Ensembl chr13:175,805...192,647
|
|
G |
Dstn |
destrin, actin depolymerizing factor |
increases expression |
ISO |
Diquat results in increased expression of DSTN protein |
CTD |
PMID:36851058 |
|
NCBI chr 3:131,284,647...131,311,361
Ensembl chr 3:131,284,648...131,311,379
|
|
G |
Dstyk |
dual serine/threonine and tyrosine protein kinase |
decreases expression |
ISO |
Diquat results in decreased expression of DSTYK protein |
CTD |
PMID:36851058 |
|
NCBI chr13:43,857,266...43,905,280
Ensembl chr13:43,857,266...43,905,269
|
|
G |
Dusp1 |
dual specificity phosphatase 1 |
increases expression |
ISO |
Diquat results in increased expression of DUSP1 mRNA |
CTD |
PMID:21172416 |
|
NCBI chr10:16,680,478...16,683,275
|
|
G |
Dusp8 |
dual specificity phosphatase 8 |
increases expression |
ISO |
Diquat results in increased expression of DUSP8 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 1:197,167,392...197,184,285
Ensembl chr 1:197,169,422...197,182,921
|
|
G |
Eci1 |
enoyl-CoA delta isomerase 1 |
increases expression |
ISO |
Diquat results in increased expression of ECI1 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr10:13,456,715...13,470,061
Ensembl chr10:13,456,563...13,470,061
|
|
G |
Ecm2 |
extracellular matrix protein 2 |
decreases expression |
ISO |
Diquat results in decreased expression of ECM2 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr17:15,120,194...15,152,536
Ensembl chr17:15,120,196...15,152,516
|
|
G |
Edil3 |
EGF like repeats and discoidin domains 3 |
decreases expression |
ISO |
Diquat results in decreased expression of EDIL3 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 2:19,890,396...20,405,028
Ensembl chr 2:19,890,373...20,405,008
|
|
G |
Egfl6 |
EGF-like-domain, multiple 6 |
decreases expression |
ISO |
Diquat results in decreased expression of EGFL6 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr X:27,884,087...27,942,044
Ensembl chr X:27,884,125...27,942,044
|
|
G |
Egflam |
EGF-like, fibronectin type III and laminin G domains |
decreases expression |
ISO |
Diquat results in decreased expression of EGFLAM mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 2:56,301,945...56,476,665
Ensembl chr 2:56,302,566...56,476,298
|
|
G |
Egr1 |
early growth response 1 |
multiple interactions increases expression |
ISO |
PROP1 protein affects the reaction [Diquat results in increased expression of EGR1 mRNA] |
CTD |
PMID:20826540 |
|
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
|
|
G |
Ehd4 |
EH-domain containing 4 |
decreases expression |
ISO |
Diquat results in decreased expression of EHD4 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 3:107,058,191...107,121,985
Ensembl chr 3:107,058,958...107,122,002
|
|
G |
Ehhadh |
enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase |
increases expression |
ISO |
Diquat results in increased expression of EHHADH mRNA |
CTD |
PMID:36851058 |
|
NCBI chr11:79,241,927...79,275,173
Ensembl chr11:79,241,938...79,275,188
|
|
G |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
increases expression |
ISO |
Diquat results in increased expression of EIF2AK3 mRNA |
CTD |
PMID:32536062 |
|
NCBI chr 4:102,805,495...102,866,914
Ensembl chr 4:102,805,510...102,866,911
|
|
G |
Eif4e2 |
eukaryotic translation initiation factor 4E family member 2 |
increases expression |
ISO |
Diquat results in increased expression of EIF4E2 protein |
CTD |
PMID:36851058 |
|
NCBI chr 9:87,886,126...87,914,470
Ensembl chr 9:87,878,085...87,914,482
|
|
G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
increases expression |
ISO |
Diquat results in increased expression of EIF4EBP1 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr16:64,792,595...64,805,984
Ensembl chr16:64,790,226...64,805,984
|
|
G |
Eif4ebp3 |
eukaryotic translation initiation factor 4E binding protein 3 |
increases expression |
ISO |
Diquat results in increased expression of EIF4EBP3 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr18:28,263,089...28,268,033
Ensembl chr18:28,162,311...28,268,024
|
|
G |
Eif6 |
eukaryotic translation initiation factor 6 |
increases expression |
ISO |
Diquat results in increased expression of EIF6 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 3:144,325,038...144,331,396
Ensembl chr 3:144,325,036...144,331,401
|
|
G |
Ell2 |
elongation factor for RNA polymerase II 2 |
increases expression |
ISO |
Diquat results in increased expression of ELL2 mRNA |
CTD |
PMID:21172416 |
|
NCBI chr 2:5,189,375...5,258,781
Ensembl chr 2:5,189,971...5,258,781
|
|
G |
Elovl7 |
ELOVL fatty acid elongase 7 |
increases expression |
ISO |
Diquat results in increased expression of ELOVL7 protein |
CTD |
PMID:36851058 |
|
NCBI chr 2:39,789,229...39,858,579
Ensembl chr 2:39,789,250...39,856,845
|
|
G |
Elp1 |
elongator acetyltransferase complex subunit 1 |
decreases expression |
ISO |
Diquat results in decreased expression of ELP1 protein |
CTD |
PMID:36851058 |
|
NCBI chr 5:71,453,338...71,505,833
Ensembl chr 5:71,456,310...71,505,762
|
|
G |
Emcn |
endomucin |
increases expression |
ISO |
Diquat results in increased expression of EMCN protein |
CTD |
PMID:36851058 |
|
NCBI chr 2:225,891,100...225,970,932
Ensembl chr 2:225,891,100...225,970,929
|
|
G |
Emid1 |
EMI domain containing 1 |
decreases expression |
ISO |
Diquat results in decreased expression of EMID1 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr14:80,000,486...80,043,561
Ensembl chr14:80,000,486...80,043,620
|
|
G |
Eml5 |
EMAP like 5 |
decreases expression |
ISO |
Diquat results in decreased expression of EML5 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 6:118,046,655...118,175,831
Ensembl chr 6:118,046,655...118,175,831
|
|
G |
Endou |
endonuclease, poly(U)-specific |
increases expression |
ISO |
Diquat results in increased expression of ENDOU mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 7:128,844,872...128,866,572
Ensembl chr 7:128,844,862...128,866,596
|
|
G |
Engase |
endo-beta-N-acetylglucosaminidase |
decreases expression |
ISO |
Diquat results in decreased expression of ENGASE protein |
CTD |
PMID:36851058 |
|
NCBI chr10:103,707,169...103,719,833
Ensembl chr10:103,707,169...103,719,819
|
|
G |
Eno1 |
enolase 1 |
increases expression |
ISO |
Diquat results in increased expression of ENO1 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 5:160,719,951...160,731,337
Ensembl chr 5:160,719,951...160,731,336
|
|
G |
Enox1 |
ecto-NOX disulfide-thiol exchanger 1 |
increases expression |
ISO |
Diquat results in increased expression of ENOX1 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr15:52,517,833...53,079,752
Ensembl chr15:52,515,178...53,079,749
|
|
G |
Entpd2 |
ectonucleoside triphosphate diphosphohydrolase 2 |
decreases expression |
ISO |
Diquat results in decreased expression of ENTPD2 protein |
CTD |
PMID:36851058 |
|
NCBI chr 3:8,213,575...8,219,094
Ensembl chr 3:8,213,663...8,226,866
|
|
G |
Eogt |
EGF domain specific O-linked N-acetylglucosamine transferase |
decreases expression |
ISO |
Diquat results in decreased expression of EOGT protein |
CTD |
PMID:36851058 |
|
NCBI chr 4:129,718,897...129,756,558
Ensembl chr 4:129,718,901...129,756,445
|
|
G |
Epb41l2 |
erythrocyte membrane protein band 4.1-like 2 |
decreases expression |
ISO |
Diquat results in decreased expression of EPB41L2 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 1:19,863,010...20,037,795
Ensembl chr 1:19,863,009...20,037,721
|
|
G |
Epha3 |
Eph receptor A3 |
decreases expression |
ISO |
Diquat results in decreased expression of EPHA3 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr11:1,138,485...1,474,102
Ensembl chr11:1,140,985...1,473,900
|
|
G |
Epha4 |
Eph receptor A4 |
decreases expression |
ISO |
Diquat results in decreased expression of EPHA4 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 9:78,815,460...78,958,139
Ensembl chr 9:78,815,460...78,958,139
|
|
G |
Ephb1 |
Eph receptor B1 |
decreases expression |
ISO |
Diquat results in decreased expression of EPHB1 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 8:102,507,549...102,944,839
Ensembl chr 8:102,507,549...102,944,839
|
|
G |
Erg |
ETS transcription factor ERG |
decreases expression |
ISO |
Diquat results in decreased expression of ERG mRNA |
CTD |
PMID:36851058 |
|
NCBI chr11:34,678,614...34,900,951
Ensembl chr11:34,678,618...34,845,871
|
|
G |
Esco2 |
establishment of sister chromatid cohesion N-acetyltransferase 2 |
decreases expression |
ISO |
Diquat results in decreased expression of ESCO2 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr15:40,034,566...40,052,295
Ensembl chr15:40,034,568...40,055,306
|
|
G |
Esm1 |
endothelial cell-specific molecule 1 |
decreases expression |
ISO |
Diquat results in decreased expression of ESM1 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 2:44,876,067...44,884,805
Ensembl chr 2:44,876,067...44,884,804
|
|
G |
Espn |
espin |
increases expression |
ISO |
Diquat results in increased expression of ESPN protein |
CTD |
PMID:36851058 |
|
NCBI chr 5:162,626,560...162,660,439
Ensembl chr 5:162,626,560...162,660,256
|
|
G |
Esr1 |
estrogen receptor 1 |
decreases expression |
ISO |
Diquat results in decreased expression of ESR1 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Ethe1 |
ETHE1, persulfide dioxygenase |
increases expression |
ISO |
Diquat results in increased expression of ETHE1 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 1:80,184,037...80,199,092
Ensembl chr 1:80,183,894...80,199,052
|
|
G |
Ets1 |
ETS proto-oncogene 1, transcription factor |
decreases expression |
ISO |
Diquat results in decreased expression of ETS1 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 8:31,045,909...31,168,010
Ensembl chr 8:31,045,945...31,168,010
|
|
G |
Evpl |
envoplakin |
increases expression |
ISO |
Diquat results in increased expression of EVPL mRNA |
CTD |
PMID:36851058 |
|
NCBI chr10:101,458,227...101,474,778
Ensembl chr10:101,458,216...101,474,763
|
|
G |
Extl1 |
exostosin-like glycosyltransferase 1 |
increases expression |
ISO |
Diquat results in increased expression of EXTL1 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 5:146,573,911...146,589,115
Ensembl chr 5:146,573,912...146,589,115
|
|
G |
F2r |
coagulation factor II (thrombin) receptor |
decreases expression |
ISO |
Diquat results in decreased expression of F2R mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 2:26,869,343...26,885,856
Ensembl chr 2:26,868,404...26,885,870
|
|
G |
F2rl3 |
F2R like thrombin or trypsin receptor 3 |
decreases expression |
ISO |
Diquat results in decreased expression of F2RL3 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr16:17,117,441...17,119,434
Ensembl chr16:17,117,441...17,119,472
|
|
G |
Fabp1 |
fatty acid binding protein 1 |
increases expression |
ISO |
Diquat results in increased expression of FABP1 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 4:103,191,015...103,194,791
Ensembl chr 4:103,191,006...103,194,788
|
|
G |
Fam163a |
family with sequence similarity 163, member A |
increases expression |
ISO |
Diquat results in increased expression of FAM163A mRNA |
CTD |
PMID:36851058 |
|
NCBI chr13:68,262,867...68,341,323
Ensembl chr13:68,262,872...68,341,049
|
|
G |
Fam20a |
FAM20A, golgi associated secretory pathway pseudokinase |
increases expression |
ISO |
Diquat results in increased expression of FAM20A mRNA |
CTD |
PMID:36851058 |
|
NCBI chr10:94,638,836...94,697,814
Ensembl chr10:94,642,850...94,697,672
|
|
G |
Fam20b |
FAM20B, glycosaminoglycan xylosylkinase |
decreases expression |
ISO |
Diquat results in decreased expression of FAM20B protein |
CTD |
PMID:36851058 |
|
NCBI chr13:68,801,663...68,839,979
Ensembl chr13:68,801,669...68,839,915
|
|
G |
Fam25a |
family with sequence similarity 25, member A |
increases expression |
ISO |
Diquat results in increased expression of FAM25A mRNA |
CTD |
PMID:36851058 |
|
NCBI chr16:9,680,668...9,684,474
Ensembl chr16:9,680,668...9,684,474
|
|
G |
Fam32a |
family with sequence similarity 32, member A |
decreases expression |
ISO |
Diquat results in decreased expression of FAM32A protein |
CTD |
PMID:36851058 |
|
NCBI chr16:17,603,054...17,607,376
Ensembl chr16:17,603,946...17,607,398
|
|
G |
Fancd2os |
FANCD2 opposite strand |
decreases expression |
ISO |
Diquat results in decreased expression of FANCD2OS mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 4:146,740,863...146,747,547
Ensembl chr 4:146,740,863...146,747,569
|
|
G |
Fbln1 |
fibulin 1 |
decreases expression |
ISO |
Diquat results in decreased expression of FBLN1 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 7:116,310,582...116,390,075
Ensembl chr 7:116,310,582...116,390,075
|
|
G |
Fbln5 |
fibulin 5 |
decreases expression |
ISO |
Diquat results in decreased expression of FBLN5 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 6:120,899,219...120,977,829
Ensembl chr 6:120,899,224...120,977,755
|
|
G |
Fbln7 |
fibulin 7 |
decreases expression |
ISO |
Diquat results in decreased expression of FBLN7 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 3:116,111,581...116,145,839
Ensembl chr 3:116,111,677...116,147,983
|
|
G |
Fbn1 |
fibrillin 1 |
decreases expression |
ISO |
Diquat results in decreased expression of FBN1 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 3:112,554,257...112,750,835
Ensembl chr 3:112,554,925...112,750,889
|
|
G |
Fbp2 |
fructose-bisphosphatase 2 |
increases expression |
ISO |
Diquat results in increased expression of FBP2 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr17:2,236,088...2,253,702
Ensembl chr17:2,236,336...2,253,698
|
|
G |
Fbxl17 |
F-box and leucine-rich repeat protein 17 |
increases expression |
ISO |
Diquat results in increased expression of FBXL17 protein |
CTD |
PMID:36851058 |
|
NCBI chr 9:102,780,573...103,206,978
Ensembl chr 9:102,782,440...103,208,950
|
|
G |
Fbxo44 |
F-box protein 44 |
increases expression |
ISO |
Diquat results in increased expression of FBXO44 protein |
CTD |
PMID:36851058 |
|
NCBI chr 5:158,583,363...158,592,510
Ensembl chr 5:158,583,366...158,592,363
|
|
G |
Fcer1g |
Fc epsilon receptor Ig |
decreases expression |
ISO |
Diquat results in decreased expression of FCER1G mRNA; Diquat results in decreased expression of FCER1G protein |
CTD |
PMID:36851058 |
|
NCBI chr13:83,649,447...83,654,248
Ensembl chr13:83,649,449...83,671,443
|
|
G |
Fcgbp |
Fc gamma binding protein |
decreases expression |
ISO |
Diquat results in decreased expression of FCGBP mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 1:83,374,979...83,413,082
Ensembl chr 1:83,372,127...83,413,083
|
|
G |
Fga |
fibrinogen alpha chain |
increases expression |
ISO |
Diquat results in increased expression of FGA mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 2:168,374,120...168,381,523
Ensembl chr 2:168,374,120...168,381,528
|
|
G |
Fgb |
fibrinogen beta chain |
increases expression |
ISO |
Diquat results in increased expression of FGB mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 2:168,394,901...168,402,863
Ensembl chr 2:168,394,916...168,405,979
|
|
G |
Fgd5 |
FYVE, RhoGEF and PH domain containing 5 |
decreases expression |
ISO |
Diquat results in decreased expression of FGD5 protein |
CTD |
PMID:36851058 |
|
NCBI chr 4:124,497,061...124,594,564
Ensembl chr 4:124,497,068...124,594,563
|
|
G |
Fgf18 |
fibroblast growth factor 18 |
increases expression |
ISO |
Diquat results in increased expression of FGF18 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr10:17,706,011...17,737,702
Ensembl chr10:17,706,174...17,736,818
|
|
G |
Fgf21 |
fibroblast growth factor 21 |
increases expression |
ISO |
Diquat results in increased expression of FGF21 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr 1:96,083,360...96,084,911
Ensembl chr 1:96,083,441...96,090,454
|
|
G |
Fgfbp1 |
fibroblast growth factor binding protein 1 |
increases expression |
ISO |
Diquat results in increased expression of FGFBP1 mRNA |
CTD |
PMID:36851058 |
|
NCBI chr14:67,103,686...67,107,492
Ensembl chr14:67,104,545...67,107,496
|
|
G |
Fgg |
fibrinogen gamma chain |
increases expression |
ISO |
Diquat results in increased expression of FGG mRNA |
CTD |
PMID:36851058 |
|
< |